Tokushima University / Educator and Researcher Directory --- Hamada, Yasuhiro

Personal Web Page

https://researchmap.jp/read0135627 (researchmap)

Field of Study

○	Department of Therapeutic Nutrition Institute
○	Department of Therapeutic Nutrition Institute
○	Department of Therapeutic Nutrition Institute

Subject of Study

○	栄養サポートチームに関する研究 (NST, therapeutic, nutrition)
○	臨床栄養に関する臨床研究
○	慢性腎臓病における Protein Energy Wasting (PEW)

Book / Paper

Book:

1.	Yasuhiro Hamada and 大村健二 : 新・栄養塾, IGAKU-SHOIN Ltd.Tokyo,Japan, Jan. 2020.
2.	Yoshiko Suzuki, Sonoko Yasui-Yamada and Yasuhiro Hamada : ナースが行う栄養指導のポイント, IGAKU SHUPPAN, Dec. 2017.
3.	Eiji Takeda, Yoshiko Suzuki, Akiko Matsumura, Yutaka Nakaya, Rie Tsutsumi, Hiroshi Sakaue, Yasuhiro Hamada, Akiko Hata and 他42人 : Guidebook of Nutrition Support Team 2017, 5th Edition, Jul. 2017.
4.	Yoshiko Suzuki, Sonoko Yasui, 西麻希, 山田静恵, Akiko Matsumura, Yu Saitou and Yasuhiro Hamada : がん患者さんの栄養管理を支える栄養サポートチーム(特集がんに対するチーム医療最前線), 四国医学会, Apr. 2017. (Summary) Several hospitals have recently established a nutrition support team(NST)for the nutritional management of inpatients. The NST includes medical doctors, nurses, dietitians, and pharmacists. The aims of the NST are to improve the nutritional condition and the quality of life(QOL)of patients. In Tokushima University Hospital, a NST was established in2002. Our team comprises physicians, surgeons, dentists, nurses, dietitians, pharmacists, dental hygienists, and physical therapists. Overall, 70% of patients undergoing a NST intervention have cancer. Nutritional management in patients with cancer plays an important role in the supportive care during cancer treatment(surgery, chemotherapy, and radiotherapy). It is focused on the improvement of undernutrition, return to oral feeding, and an improvement in QOL in palliative care. Recently, cancer cachexia has received a lot of attention, with various studies reporting on the nutritional care in patients with cancer. Malnutrition negatively impacts a patient's response to therapy, leading to an increase in the incidence of treatment-related side effects, and impairment in muscle function, performance status, immune function, and QOL. Recently, it has been reported that NST improves the treatment outcome in patients with cancer because nutritional status is an important part of cancer treatment. Therefore, nutritional management by a NST in patients with cancer has played a crucial role in cancer therapy. (Keyword) NST / cancer, malnutrition / nutritional management (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050583647830806912 (CiNii: 1050583647830806912)
5.	Yoshiko Suzuki, Sonoko Yasui and Yasuhiro Hamada : 児童生徒の食と病気 (2) 小児腎疾患の食事と生活, 全国学校栄養士協議会, Apr. 2017.
6.	Yasuhiro Hamada : 病棟栄養士のためのベーシックセミナー, 医歯薬出版株式会社, Apr. 2017.
7.	菊井聡子, 筑後桃子, 小笠原有加, 長尾紀子, Akiko Matsumura, Yasuhiro Hamada and Akio Kuroda : カーボカウントを用いた血糖値コントロール法, 富士フィルムファーム株式会社, Apr. 2017.
8.	Yasuhiro Hamada : 酸・塩基平衡, Nankodo, Mar. 2017. (Keyword) 酸・塩基とは / pHの重要性と緩衝系 / アニオンギャップ / 血清カリウム濃度 / 血液ガス
9.	Yasuhiro Hamada : 病棟栄養士のための臨床栄養ベーシックセミナー, 医歯薬出版株式会社, 2017.
10.	西麻希 and Yasuhiro Hamada : CKD患者におけるサルコペニアとフレイルについて教えて下さい．, 株式会社中外医学社, Jun. 2016.
11.	Yasuhiro Hamada : 栄養支援で医療の質の向上へ, バリューメディカル, Aug. 2015.
12.	Yasuhiro Hamada, Sonoko Yasui and Yu Saitou : 根拠に基づいた経腸栄養剤の選択腎疾患, フジメディカル出版, Mar. 2015.
13.	Yasuhiro Hamada, Kazuyoshi Kawazoe, Naoto Okada, 谷佳子, 西麻希, Akiko Matsumura and Sonoko Yasui : これでOK!静脈栄養のレシピ, 株式会社じほう, Tokyo, Feb. 2015.
14.	Sonoko Yasui and Yasuhiro Hamada : 栄養サポートチーム(NST), 中外医学社, Aug. 2014.
15.	Yasuhiro Hamada : 演習症例, Medical Review Co.,Ltd, Jun. 2014.
16.	Yasuhiro Hamada : 電解質異常，酸塩基平衡異常, Medical Review Co.,Ltd, Jun. 2014.
17.	Yasuhiro Hamada and Sonoko Yasui : リン摂取と慢性腎臓病, KENPAKUSHA, Tokyo, May 2014.
18.	Yasuhiro Hamada, Sonoko Yasui and Usami Makoto : Free Radicals and Diabetic Bone Disorder, Springer, May 2014. (Link to Publication Site) ● Publication site (DOI): 10.1007/978-3-642-30018-9_129 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.1007/978-3-642-30018-9_129 (DOI: 10.1007/978-3-642-30018-9_129)
19.	Yasuhiro Hamada : 栄養投与法選択の基本, じほう社, Feb. 2014.
20.	Yasuhiro Hamada and 深川雅史 : 骨・ミネラル代謝異常, 中山書店, Oct. 2013.
21.	Yasuhiro Hamada : 酸化ストレスマーカー, 日本メディカルセンター, Jun. 2013.
22.	Yasuhiro Hamada : 透析患者の栄養状態に関する検査の進め方, 日本メディカルセンター, Jun. 2013.
23.	Yasuhiro Hamada : 栄養状態の評価と食事管理, 日本メディカルセンター, Jun. 2013.
24.	Yasuhiro Hamada : 食事療法, Iyaku Journal Co., Ltd., Osaka, May 2013.
25.	門口啓, Yasuhiro Hamada and 深川雅史 : 腎臓病患者の栄養, 医学書院, Jan. 2013.

Academic Paper (Judged Full Paper):

1.	Miyu Kubo, Sonoko Yasui-Yamada, Haruka Hayashi, Midori Kitao, Kyoko Wada, Ayaka Yamanaka, Nao Ohmae, Momoyo Matsuoka, Seiichiro Kamimura, Aki Shimada, Yoshiaki Kitamura and Yasuhiro Hamada : Development and validation of equations for predicting appendicular skeletal muscle mass in male patients with head and neck cancer and normal hydration status, Nutrition, Vol.116, 112184, 2023. (Summary) Muscle mass is typically assessed by abdominal computed tomography, magnetic resonance imaging, and dual-energy x-ray absorptiometry. However, these tests are not routinely performed in patients with head and neck cancer (HNC), making sarcopenia assessment difficult. The aim of this study was to develop and validate equations for predicting appendicular skeletal muscle mass (ASM) from data obtained in daily medical practice, with bioelectrical impedance analysis (BIA)-measured appendicular skeletal muscle mass (BIA-ASM) as a reference. This cross-sectional study included 103 men with HNC who were randomly placed into development and validation groups. The prediction equations for BIA-ASM were developed by multiple regression analysis and validated by Bland-Altman analyses. The estimated skeletal muscle mass index (eSMI) was also statistically evaluated to discriminate the cutoff value for BIA-measured SMI according to the Asian Working Groups for Sarcopenia. Two practical equations, which included 24-h urinary creatinine excretion volume (24hUCrV), handgrip strength (HGS), body weight (BW), and body height (BHt), were developed: ASM (kg) = -39.46 + (3.557 × 24hUCrV [g]) + (0.08872 × HGS [kg]) + (0.1263 × BW [kg]) + (0.2661 × BHt [cm]) if available for 24hUCrV (adjusted R = 0.8905), and ASM (kg) = -42.60 + (0.1643 × HGS [kg]) + (0.1589 × BW [kg]) + (0.2807 × BHt [cm]) if not (adjusted R = 0.8589). ASM estimated by these two equations showed a significantly strong correlation with BIA-ASM (R > 0.900). Bland-Altman analyses showed a good agreement, and eSMI accuracy was high (>80%) in both equations. These two equations are a valid option for estimating ASM and diagnosing sarcopenia in patients with HNC in all facilities without special equipment. (Keyword) Humans / Male / Sarcopenia / Cross-Sectional Studies / Hand Strength / Muscle, Skeletal / Body Composition / Body Weight / Head and Neck Neoplasms / Absorptiometry, Photon / Electric Impedance (Tokushima University Institutional Repository) ● Metadata: 119183 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.nut.2023.112184 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37678015 ● Search Scopus @ Elsevier (PMID): 37678015 ● Search Scopus @ Elsevier (DOI): 10.1016/j.nut.2023.112184 (Tokushima University Institutional Repository: 119183, DOI: 10.1016/j.nut.2023.112184, PubMed: 37678015)
2.	Nao Omae, Sonoko Yasui-Yamada, Taiki Furumoto, Kyoko Wada, Haruka Hayashi, Midori Kitao, YAMANAKA Ayaka, Miyu Kubo, Momoyo Matsuoka, Seiichiro Kamimura, Aki Shimada, Nori Sato, Yoshiaki Kitamura, Shinsuke Katoh, Noriaki Takeda and Yasuhiro Hamada : Muscle mass, quality, and strength; physical function and activity; and metabolic status in cachectic patients with head and neck cancer., Clinical Nutrition ESPEN, Vol.53, 113-119, 2023. (Summary) Cancer cachexia is commonly associated with poor prognosis in patients with head and neck cancer (HNC). However, its pathophysiology and treatment are not well established. The current study aimed to assess the muscle mass/quality/strength, physical function and activity, resting energy expenditure (REE), and respiratory quotient (RQ) in cachectic patients with HNC. This prospective cross-sectional study analyzed 64 patients with HNC. Body composition was measured via direct segmental multifrequency bioelectrical impedance analysis, and muscle quality was assessed using echo intensity on ultrasonography images. Muscle strength was investigated utilizing handgrip strength and isometric knee extension force (IKEF). Physical function was evaluated using the 10-m walking speed test and the five times sit-to-stand (5-STS) test. Physical activity was examined using a wearable triaxial accelerometer. REE and RQ were measured via indirect calorimetry. These parameters were compared between the cachectic and noncachectic groups. In total, 23 (36%) patients were diagnosed with cachexia. The cachectic group had a significantly lower muscle mass than the noncachectic group. Nevertheless, there was no significant difference in terms of fat between the two groups. The cachectic group had a higher quadriceps echo intensity and a lower handgrip strength and IKEF than the noncachectic group. Moreover, they had a significantly slower normal and maximum walking speed and 5-STS speed. The number of steps, total activity time, and time of activity (<3 Mets) did not significantly differ between the two groups. The cachectic group had a shorter time of activity (≥3 Mets) than the noncachectic group. Furthermore, the cachectic group had a significantly higher REE/body weight and REE/fat free mass and a significantly lower RQ than the noncachectic group. The cachectic group had a lower muscle mass/quality/strength and physical function and activity and a higher REE than the noncachectic group. Thus, REE and physical activity should be evaluated to determine energy requirements. The RQ was lower in the cachectic group than that in the noncachectic group, indicating changes in energy substrate. Further studies must be conducted to examine effective nutritional and exercise interventions for patients with cancer cachexia. (Keyword) Humans / Cachexia / Hand Strength / Cross-Sectional Studies / Prospective Studies / Head and Neck Neoplasms / Quadriceps Muscle (Tokushima University Institutional Repository) ● Metadata: 118202 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.clnesp.2022.12.006 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36657901 ● Search Scopus @ Elsevier (PMID): 36657901 ● Search Scopus @ Elsevier (DOI): 10.1016/j.clnesp.2022.12.006 (Tokushima University Institutional Repository: 118202, DOI: 10.1016/j.clnesp.2022.12.006, PubMed: 36657901)
3.	Nanami Nasu, Sonoko Yasui-Yamada, Natsumi Kagiya, Mami Takimoto, Yumiko Kurokawa, Yoshiko Suzuki, Hideya Kashihara, Yu Saitou, Masaaki Nishi, Mitsuo Shimada and Yasuhiro Hamada : Muscle strength is a stronger prognostic factor than muscle mass in patients with gastrointestinal and hepatobiliary-pancreatic cancers., Nutrition, Vol.103-104, 111826, 2022. (Summary) Sarcopenia has been reported as a prognostic risk factor in patients with gastrointestinal (GI) and hepatobiliary pancreatic (HBP) cancers. This study aimed to investigate whether the loss of muscle mass or strength is a stronger prognostic factor, and explore the cutoff values of skeletal muscle mass index (SMI) and handgrip strength (HGS) based on the survival outcome in patients with GI and HBP cancers. A total of 480 elderly patients with primary GI and HBP cancers who underwent their first resection surgery were analyzed retrospectively. Patients were divided into four groups: Appropriate SMI and HGS, low SMI alone, low HGS alone, and low SMI and HGS. Low SMI was derived from a bioelectrical impedance analysis, and low HGS was defined according to the Asian Working Group for Sarcopenia 2019 criteria. The multivariate analysis showed that low SMI was a significant risk factor for mortality in men only, but low HGS was significant in both sexes. From the multivariate analysis of the four groups, low HGS alone and low SMI and HGS showed a significantly higher hazard ratio than appropriate SMI and HGS in both sexes. An SMI of 7.21 kg/m and HGS of 28 kg were obtained as cutoff values based on the 3-y survival outcomes in men. Low muscle strength was a stronger prognostic factor than low muscle mass. Therefore, measuring muscle strength in all patients is essential. (Keyword) Male / Female / Humans / Aged / Sarcopenia / Hand Strength / Prognosis / Retrospective Studies / Muscle Strength / Muscle, Skeletal / Pancreatic Neoplasms (Tokushima University Institutional Repository) ● Metadata: 118201 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.nut.2022.111826 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36122543 ● Search Scopus @ Elsevier (PMID): 36122543 ● Search Scopus @ Elsevier (DOI): 10.1016/j.nut.2022.111826 (Tokushima University Institutional Repository: 118201, DOI: 10.1016/j.nut.2022.111826, PubMed: 36122543)
4.	Ayaka Yamanaka, Sonoko Yasui-Yamada, Taiki Furumoto, Miyu Kubo, Haruka Hayashi, Midori Kitao, Kyoko Wada, Nao Ohmae, Seiichiro Kamimura, Aki Shimada, Nori Sato, Shinsuke Katoh, Noriaki Takeda and Yasuhiro Hamada : Association of phase angle with muscle function and prognosis in patients with head and neck cancer undergoing chemoradiotherapy, Nutrition, 111798, 2022. (Summary) Objective: We aimed to investigate the correlation of phase angle (PhA) with other parameters (e.g., muscle mass/quality/strength and physical function), assess the prognostic relevance of pre-chemoradiotherapy (CRT) PhA, and suggest a reference value of PhA in Asian patients with head and neck cancer (HNC). Research Methods & Procedures: Ninety-six patients with HNC who underwent CRT were divided into two groups, maintained-PhA group and low-PhA group, according to the PhA 25th percentile values by sex. Pretreatment PhA was measured using direct segmental multi-frequency bioelectrical impedance analysis, and muscle quality was assessed using echo intensity in ultrasound images. Correlation of PhA with other parameters was investigated, and between-group differences with respect to adverse events, treatment interruption, and 3-year survival were assessed. Results: PhA showed a positive correlation with isometric knee extension force (R = 0.710), handgrip strength (R = 0.649), skeletal muscle mass index (R = 0.620), and maximum gait speed (R = 0.543) (P < 0.001). PhA showed a negative correlation with echo intensity (R = -0.439) and five times sit-to-stand test (R = -0.505) (P < 0.01). The low-PhA group had a higher incidence of severe anemia (52% in low-PhA vs. 17% in maintained-PhA), aspiration (17% vs. 1%), radiotherapy interruption (17% vs. 3%), and poor 3-year survival (47% vs. 81%) than the maintained-PhA group (P < 0.05). Conclusion: PhA was correlated with muscle mass/quality/strength, and physical function. Low PhA was associated with severe adverse events, treatment interruption, and shorter survival. These findings suggested that 4.6° for men and 4.0° for women may be useful as prognostic reference values in Asian patients with HNC. (Keyword) Phase angle / Muscle strength / Muscle quality / Physical function / Prognosis / Head and neck cancer (Tokushima University Institutional Repository) ● Metadata: 117379 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.nut.2022.111798 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1360298757183486592 ● Search Scopus @ Elsevier (DOI): 10.1016/j.nut.2022.111798 (Tokushima University Institutional Repository: 117379, DOI: 10.1016/j.nut.2022.111798, CiNii: 1360298757183486592)
5.	Masato Tagi, Mari Tajiri, Yasuhiro Hamada, Yoshifumi Wakata, Xiao Shan, Kazumi Ozaki, Masanori Kubota, Sosuke Amano, Hiroshi Sakaue, Yoshiko Suzuki and Jun Hirose : Accuracy of an Artificial Intelligence-Based Model for Estimating Leftover Liquid Food in Hospitals: Validation Study., JMIR Formative Research, Vol.6, No.5, e35991, 2022. (Summary) An accurate evaluation of the nutritional status of malnourished hospitalized patients at a higher risk of complications, such as frailty or disability, is crucial. Visual methods of estimating food intake are popular for evaluating the nutritional status in clinical environments. However, from the perspective of accurate measurement, such methods are unreliable. The accuracy of estimating leftover liquid food in hospitals using an artificial intelligence (AI)-based model was compared to that of visual estimation. The accuracy of the AI-based model (AI estimation) was compared to that of the visual estimation method for thin rice gruel as staple food and fermented milk and peach juice as side dishes. A total of 576 images of liquid food (432 images of thin rice gruel, 72 of fermented milk, and 72 of peach juice) were used. The mean absolute error, root mean squared error, and coefficient of determination (R) were used as metrics for determining the accuracy of the evaluation process. Welch t test and the confusion matrix were used to examine the difference of mean absolute error between AI and visual estimation. The mean absolute errors obtained through the AI estimation approach were 0.63 for fermented milk, 0.25 for peach juice, and 0.85 for the total. These were significantly smaller than those obtained using the visual estimation approach, which were 1.40 (P<.001) for fermented milk, 0.90 (P<.001) for peach juice, and 1.03 (P=.009) for the total. By contrast, the mean absolute error for thin rice gruel obtained using the AI estimation method (0.99) did not differ significantly from that obtained using visual estimation (0.99). The confusion matrix for thin rice gruel showed variation in the distribution of errors, indicating that the errors in the AI estimation were biased toward the case of many leftovers. The mean squared error for all liquid foods tended to be smaller for the AI estimation than for the visual estimation. Additionally, the coefficient of determination (R) for fermented milk and peach juice tended to be larger for the AI estimation than for the visual estimation, and the R value for the total was equal in terms of accuracy between the AI and visual estimations. The AI estimation approach achieved a smaller mean absolute error and root mean squared error and a larger coefficient of determination (R) than the visual estimation approach for the side dishes. Additionally, the AI estimation approach achieved a smaller mean absolute error and root mean squared error compared to the visual estimation method, and the coefficient of determination (R) was similar to that of the visual estimation method for the total. AI estimation measures liquid food intake in hospitals more precisely than visual estimation, but its accuracy in estimating staple food leftovers requires improvement. (Tokushima University Institutional Repository) ● Metadata: 117555 (Link to Publication Site) ● Publication site (DOI): 10.2196/35991 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35536638 ● Search Scopus @ Elsevier (PMID): 35536638 ● Search Scopus @ Elsevier (DOI): 10.2196/35991 (Tokushima University Institutional Repository: 117555, DOI: 10.2196/35991, PubMed: 35536638)
6.	Mami Takimoto, Sonoko Yasui-Yamada, Nanami Nasu, Natsumi Kagiya, Nozomi Aotani, Yumiko Kurokawa, Yoshiko Suzuki, Hideya Kashihara, Yu Saitou, Masaaki Nishi, Mitsuo Shimada and Yasuhiro Hamada : Development and Validation of Cutoff Value for Reduced Muscle Mass for GLIM Criteria in Patients with Gastrointestinal and HepatobiliaryPancreatic Cancers, Nutrients, Vol.14, No.943, 1-10, 2022. (Summary) The Global Leadership Initiative on Malnutrition (GLIM) criteria recommends using race- and sex-adjusted cutoff values for reduced muscle mass (RMM), but the only cutoff values available for Asians are the skeletal muscle mass index (SMI) established by the Asian Working Group for Sarcopenia (AWGS). This retrospective study aimed to develop and validate cutoff values for the fat-free mass index (FFMI) and arm circumference (AC) of Asians, and to investigate the association between GLIM malnutrition and prognosis. A total of 660 patients with primary gastrointestinal (GI) and hepatobiliary-pancreatic (HBP) cancers who underwent their first resection surgery were recruited and randomly divided into development and validation groups. The FFMI and AC cutoff values were calculated by receiver operating characteristic curve analysis for the AWGS SMI as the gold standard. The cutoff values for each RMM were used to diagnose malnutrition on the basis of GLIM criteria, and the survival rates were compared. The optimal FFMI cutoff values for RMM were 17 kg/m for men and 15 kg/m for women, and for AC were 27 cm for men and 25 cm for women. In the validation group, the accuracy of the FFMI and AC cutoff values to discriminate RMM were 85.2% and 68.8%, respectively. Using any of the three measures of RMM, overall survival rates were significantly lower in the GLIM malnutrition group. In conclusion, the cutoff values for the FFMI and AC in this study could discriminate RMM, and GLIM malnutrition using these cutoff values was associated with decreased survival. (Keyword) Female / Humans / Leadership / Male / Malnutrition / Muscles / Pancreatic Neoplasms / Retrospective Studies (Tokushima University Institutional Repository) ● Metadata: 116863 (Link to Publication Site) ● Publication site (DOI): 10.3390/nu14050943 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35267918 ● Search Scopus @ Elsevier (PMID): 35267918 ● Search Scopus @ Elsevier (DOI): 10.3390/nu14050943 (Tokushima University Institutional Repository: 116863, DOI: 10.3390/nu14050943, PubMed: 35267918)
7.	Nozomi Aotani, Sonoko Yasui-Yamada, Natsumi Kagiya, TAKIMOTO Mami, Yu Ohiwa, Matsubara Atsumi, Sayaka Matsura, Mayu Tanimura, Yoshiko Suzuki, Hideya Kashihara, Yu Saitou, Masaaki Nishi, Mitsuo Shimada and Yasuhiro Hamada : Malnutrition by European Society for Clinical Nutrition and Metabolism criteria predicts prognosis in patients with gastrointestinal and hepatobiliary-pancreatic cancer, Clinical Nutrition ESPEN, Vol.42, 265-271, 2021. (Summary) The European Society for Clinical Nutrition and Metabolism (ESPEN) proposed the ESPEN diagnostic criteria (EDC) for malnutrition in 2015. There is no report on the association between the EDC and prognosis in patients with gastrointestinal (GI) and hepatobiliary-pancreatic (HBP) cancer. This study aimed to (1) determine the prevalence of EDC malnutrition, (2) investigate the validity of the EDC as a nutritional and prognostic indicator, and (3) examine which components of the EDC are most related to long-term prognosis in patients with GI and HBP cancers. A total of 634 patients with primary GI and HBP cancers who underwent their first resection surgery between July 2014 and March 2018 were retrospectively recruited. According to the EDC, patients were divided into malnourished and non-malnourished groups. Clinical parameters and survival between these two groups were compared. The prognostic effects of the EDC and the EDC components were analyzed using Cox proportional hazard models. The prevalence of EDC malnutrition was 22%. Anthropometric data and biochemical data were associated with EDC malnutrition. The 5-year survival rate was lower in the malnourished group (72%) than in the non-malnourished group (73%; P = 0.007). The multivariate analysis demonstrated that the malnourished group was an independent risk factor for mortality (hazard ratio = 1.70 in the malnourished group; 95% confidence interval 1.08-2.63; P = 0.024). Among EDC components, body mass index (BMI) of <18.5 kg/m was an independent poor prognostic factor. EDC malnutrition is associated with poor postoperative long-term prognosis. Among the EDC components, BMI of <18.5 kg/m is most associated with prognosis in patients with preoperative GI and HBP cancers. (Tokushima University Institutional Repository) ● Metadata: 115904 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.clnesp.2021.01.023 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33745591 ● Summary page in Scopus @ Elsevier: 2-s2.0-85100771924 (Tokushima University Institutional Repository: 115904, DOI: 10.1016/j.clnesp.2021.01.023, PubMed: 33745591, Elsevier: Scopus)
8.	Mayumi Yano, Arisa Inoue, A Toda, M Takahashi and Yasuhiro Hamada : Clinical characteristics of hyponatremia in patients receiving nutrition support : A cross-sectional study evaluated by bioelectrical impedance analysis., The Journal of Medical Investigation : JMI, Vol.68, No.1.2, 112-118, 2021. (Summary) Background & aims : We investigated the contributing factors of hyponatremia in patients on nutrition support using bioelectrical impedance analysis (BIA). Methods : Thirty patients administered enteral or parenteral nutrition support for at least 72 hours were studied. We collected nutritional and electrolyte intake, serum biochemical parameters, and body composition measured by BIA. Patients were classified into two groups according to their serum sodium levels : (1) Normanatremia group, 135-145 mEq / L (n = 18) and (2) Hyponatremia group, less than 135 mEq / L (n = 12), and their characteristics were analyzed. Results : There were no significant differences between the Normonatremia and Hyponatremia groups in terms of energy, protein, and sodium intake. Serum biochemical parameters other than serum sodium and chloride levels were comparable between the two groups. On the other hand, the ratio of extracellular water to total body water (ECW / TBW) obtained by BIA was significantly higher in the Hyponatremia group than in the Normonatremia group. Further, an elevated ECW / TBW significantly and negatively correlated with serum albumin level. Conclusions : Regardless of sodium intake, higher ECW / TBW was associated with hyponatremia in patients on nutrition support. ECW / TBW may be an important clinical parameter relevant to the nutritional care of hyponatremia. J. Med. Invest. 68 : 112-118, February, 2021. (Tokushima University Institutional Repository) ● Metadata: 115971 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.68.112 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33994454 ● Search Scopus @ Elsevier (PMID): 33994454 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.68.112 (Tokushima University Institutional Repository: 115971, DOI: 10.2152/jmi.68.112, PubMed: 33994454)
9.	Ayami Kashiji, Mari Tajiri, Momoko Chikugo, Nomura Satoko, Sonoko Yasui-Yamada, Yoshiko Suzuki and Yasuhiro Hamada : Hyponatremia is a Prognostic Factor in Patients Receiving Nutrition Support., The American Journal of the Medical Sciences, Vol.S0002-9629, No.20, 30513-30519, 2020. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.amjms.2020.11.025 (Link to Search Site for Scientific Articles) ● Summary page in Scopus @ Elsevier: 2-s2.0-85105112505 (DOI: 10.1016/j.amjms.2020.11.025, Elsevier: Scopus)
10.	Sonoko Yasui-Yamada, Yu Oiwa, Yu Saitou, Aotani Nozomi, Matsubara Atsumi, Matsuura Sayaka, Tanimura Mayu, Yoshiko Suzuki, Hideya Kashihara, Masaaki Nishi, Mitsuo Shimada and Yasuhiro Hamada : Impact of phase angle on postoperative prognosis in patients with gastrointestinal and hepatobiliary-pancreatic cancer, Nutrition, Vol.79-80, 110891, 2020. (Tokushima University Institutional Repository) ● Metadata: 115901 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.nut.2020.110891 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 32731162 ● Summary page in Scopus @ Elsevier: 2-s2.0-85088663807 (Tokushima University Institutional Repository: 115901, DOI: 10.1016/j.nut.2020.110891, PubMed: 32731162, Elsevier: Scopus)
11.	Arisa Hamano, E Ishikawa, T Murata, C Miki and Yasuhiro Hamada : Effects of Protein-Energy Wasting (PEW) and hyperphosphatemia on the prognosis in Japanese maintenance hemodialysis patients: A five-year follow-up observational study., Clinical Nutrition ESPEN, Vol.36, 134-138, 2020. (Summary) In dialysis patients, malnutrition is a poor prognostic factor. In patients with chronic kidney disease (CKD), malnutrition is qualitatively different from general malnutrition, which is defined as "Protein-Energy Wasting (PEW)." Dietary therapy for the enhancement of PEW requires the aggressive intake of protein. Conversely, as protein intake and phosphorus intake correlate positively, increasing the protein intake increases the phosphorus intake, which is a poor prognostic factor in dialysis patients. One of the treatments for hyperphosphatemia in dialysis patients is the intake restriction of phosphorus by dietary counseling. However, protein uptake to maintain and augment the nutritional status and the protein intake restriction to correct hyperphosphatemia are contradictory treatments. Hence, this study aims to investigate the effects of PEW and hyperphosphatemia on the prognosis in hemodialysis patients. We enrolled 60 outpatients who underwent maintenance hemodialysis for 6 months (May-November 2012) at Iga City General Hospital (Mie, Japan). In November 2012, we assessed the presence or absence of PEW and hyperphosphatemia in patients and evaluated the survival rate over the next 5 years. Overall, 10 patients (17%) were diagnosed as PEW. While 17 patients (28%) exhibited average phosphorus level >6.0 mg/dL (hyperphosphatemia). The 5-year survival rate was 30% in the PEW group, 66% in the non-PEW group, 57% in the hyperphosphatemia group, and 61% in the non-hyperphosphatemia group. A statistically significant difference existed between the PEW and non-PEW groups (P = 0.021). However, we observed no significant difference between the hyperphosphatemia and non-hyperphosphatemia groups. This study suggests that PEW affects the prognosis more than hyperphosphatemia in maintenance hemodialysis patients. The normalization of the serum phosphorus level by the protein intake restriction could prevent secondary hyperparathyroidism and vascular calcification. Conversely, restricting the protein intake poses a risk of malnutrition. In fact, early death occurred in patients with PEW in this study. Perhaps, patients with PEW should prioritize improving their nutritional status rather than controlling the serum phosphorus level. (Keyword) Aged / Body Mass Index / Cachexia / Eating / Female / Follow-Up Studies / Humans / Hyperphosphatemia / Japan / Male / Malnutrition / Middle Aged / Nutritional Status / Prognosis / Protein-Energy Malnutrition / Renal Dialysis / Renal Insufficiency, Chronic / Survival Rate (Tokushima University Institutional Repository) ● Metadata: 119315 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.clnesp.2020.01.004 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 32220356 ● Search Scopus @ Elsevier (PMID): 32220356 ● Search Scopus @ Elsevier (DOI): 10.1016/j.clnesp.2020.01.004 (Tokushima University Institutional Repository: 119315, DOI: 10.1016/j.clnesp.2020.01.004, PubMed: 32220356)
12.	Takaaki Shimohata, Kazuaki Mawatari, Takashi Uebanso, Airi Honjo, Akari Tsunedomi, Sho Hatayama, Yuri Sato, Junko Kido, Risa Nishisaka, Ayumi Yoshimoto, Tomoko Yamashita, Sachie Amano, Miki Maetani-Yasui, Hitomi Iba, Yumi Harada, Mutsumi Nakahashi, Sonoko Yasui-Yamada, Yasuhiro Hamada, Tadahiko Nakagawa, Masahiro Sogabe, Takahiro Emoto, Masatake Akutagawa, Toshiya Okahisa, Yohsuke Kinouchi and Akira Takahashi : Bacterial Contamination of Hemodialysis Devices in Hospital Dialysis Wards., The Journal of Medical Investigation : JMI, Vol.66, No.1.2, 148-152, 2019. (Summary) Chronic care patients undergoing hemodialysis for treatment of end-stage renal failure experience higher rates of bloodstream-associated infection due to the patients' compromised immune system and management of the bloodstream through catheters. Staphylococcus species are acommon cause of hemodialysis catheterrelated bloodstream infections. We investigated environmental bacterial contamination of dialysis wards and contamination of hemodialysis devices to determine the source of bacteria for these infections. All bacterial samples were collected by the swab method and the agarose stamp method. And which bacterium were identified by BBL CRYSTAL Kit or 16s rRNA sequences. In our data, bacterial cell number of hemodialysis device was lower than environment of patient surrounds. But Staphylococcus spp. were found predominantly on the hemodialysis device (46.8%), especially on areas frequently touched by healthcare-workers (such as Touch screen). Among Staphylococcus spp., Staphylococcus epidermidis was most frequently observed (42.1% of Staphylococcus spp.), and more surprising, 48.2% of the Staphylococcus spp. indicated high resistance for methicillin. Our finding suggests that hemodialysis device highly contaminated with bloodstream infection associated bacteria. This study can be used as a source to assess the risk of contamination-related infection and to develop the cleaning system for the better prevention for bloodstream infections in patients with hemodialysis. J. Med. Invest. 66 : 148-152, February, 2019. (Tokushima University Institutional Repository) ● Metadata: 113411 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.66.148 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31064928 ● Search Scopus @ Elsevier (PMID): 31064928 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.66.148 (Tokushima University Institutional Repository: 113411, DOI: 10.2152/jmi.66.148, PubMed: 31064928)
13.	Sayaka Matsuura, Yumi Sirai, Miyu Kubo, Chisako Nayama, Masami Okitsu, Yu Ohiwa, Sonoko Yasui-Yamada, Yoshiko Suzuki, Tomohiro Murata, Eiji Ishikawa, Chikao Miki and Yasuhiro Hamada : Body fat mass is correlated with serum trasthyreti levels i maiteace hemodialysis patients., The Journal of Medical Investigation : JMI, Vol.64, No.3,4, 222-227, 2017. (Summary) Serum transthyretin (TTR), also known as prealbumin, is a reliable nutritional indicator and an independent prognostic factor for maintenance hemodialysis patients. However, we recently reported that serum TTR levels did not affect protein-energy wasting (PEW). In this study, we investigated factors affecting serum TTR levels in 60 maintenance hemodialysis patients. The patients were divided into High-TTR and Low-TTR groups according to the median serum TTR level. Albumin levels were significantly higher and C-reactive protein (CRP) levels were significantly lower in the High-TTR group than in the Low-TTR group. Although body fat mass was significantly higher in the High-TTR group than in the Low-TTR group, no significant difference in body fat ratio were observed. These findings suggest that body fat mass is related to serum TTR levels, apart from factors such as albumin and CRP levels, which showed correlations with serum TTR levels. Because body fat mass is related to better survival in maintenance hemodialysis patients, it may contribute to the prognostic value of serum TTR levels. In addition, in such patients, it may be important to evaluate body fat mass rather than body fat ratio and to maintain the minimum necessary body fat mass. J. Med. Invest. 64: 222-227, August, 2017. (Keyword) Adipose Tissue / Aged / Female / Humans / Male / Middle Aged / Prealbumin / Renal Dialysis / Serum Albumin (Tokushima University Institutional Repository) ● Metadata: 111120 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.64.222 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28954986 ● Summary page in Scopus @ Elsevier: 2-s2.0-85030261792 (Tokushima University Institutional Repository: 111120, DOI: 10.2152/jmi.64.222, PubMed: 28954986, Elsevier: Scopus)
14.	Yukie Nakashita, Tomoya Sano, Hiroaki Yoshioka, Tomoki Shimada, Ryotaro Hori, Makoto Usami and Yasuhiro Hamada : Nonconcordant regulation of mitochondrial respiratory complexes in the kidneys of 5/6 nephrectomized mice., The Journal of Medical Investigation : JMI, Vol.64, No.3,4, 255-261, 2017. (Summary) Hyperglycemia induces nonconcordant regulation of renal mitochondrial respiratory complexes, increases oxidative stress, and causes diabetic nephropathy. Hypertension is a complication associated with diabetes and involves glomerular hyperfiltration, the effects of which on mitochondrial respiratory complexes are not well understood. To investigate the effect of glomerular hyperfiltration on renal mitochondrial respiratory complexes, we used the 5/6 nephrectomized BKS. Cg-Dock7+/+Lepr/J, Dock7+/+Lepr mice (db/m-5/6Nx mice) as a model for glomerular hyperfiltration. The BKS. Cg-Dock7+/+Lepr/J, +Lepr/+Lepr mice (db/db mice), a model for type 2 diabetes, was used as the positive control. We investigated the activities and protein levels of the mitochondrial complex, and the mitochondrial DNA and adenosine triphosphate content in the kidneys of these models. Blood chemistry and renal histopathological examination were performed for characterization of the disease. Both models showed expansion of the mesangial matrix of the glomeruli, which is indicative of glomerular hyperfiltration. The activities of complexes I and IV and the protein levels of complexes I and III were nonconcordant in db/m-5/6Nx mice. In conclusion, we demonstrated that nonconcordant regulation of mitochondrial complexes in db/m-5/6Nx mice involved with glomerular hyperfiltration. The progression and/or severity of nephropathy might be affected through a synergistic effect of mitochondrial dysfunction in hyperglycemia and glomerular hyperfiltration. J. Med. Invest. 64: 255-261, August, 2017. (Keyword) db/m-5/6 nephrectomized mice / db/db mice / glomerular hyperfiltration / mitochondrial respiratory complex (Tokushima University Institutional Repository) ● Metadata: 111127 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.64.255 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28954992 ● Search Scopus @ Elsevier (PMID): 28954992 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.64.255 (Tokushima University Institutional Repository: 111127, DOI: 10.2152/jmi.64.255, PubMed: 28954992)
15.	Makoto Miyoshi, Manami Ueno, Mari Matsuo, Yasuhiro Hamada, Michiko Takahashi, Masashi Yamamoto, Ikuko Yamamoto, Reiko Mikajiri, Satoko Tabuchi, Kumiko Wakida, Misa Yamanishi, Midori Hirai and Makoto Usami : Effect of dietary fatty acid and micronutrient intake/energy ratio on serum diamine oxidase activity in healthy woman., Nutrition, Vol.39, No.40, 67-70, 2017. (Summary) Serum diamine oxidase (DAO) activity varies to a greater extent in women than in men. DAO activity during the luteal phase was higher than that during the follicular phase in healthy women. Recent reports have indicated that duodenal lipid infusion increased DAO activity in the intestinal lymph in rats. The aim of this study was to elucidate the effect of dietary nutrient intake on serum DAO activity in healthy women. Thirty-four healthy Japanese women were recruited. Food surveys were performed using dietary records for 3 d during both the follicular and luteal phases. Nutrient intake was calculated and expressed as the energy intake ratio. The correlation between DAO activity and nutrient intake was analyzed. Serum DAO activity in both phases was positively correlated with intake of long-chain fatty acids, saturated fatty acids, and monounsaturated fatty acids (P < 0.05). Intake of phosphorus, calcium, zinc, magnesium, iron, and vitamin B during the luteal phase was positively correlated with serum DAO activity (P < 0.05). In healthy women, serum DAO activity was influenced by dietary fatty acid and micronutrient intake. (Keyword) Adult / Amine Oxidase (Copper-Containing) / Dietary Fats / Energy Intake / Fatty Acids / Female / Humans / Micronutrients / Nutritional Status / Young Adult (Link to Publication Site) ● Publication site (DOI): 10.1016/j.nut.2017.03.004 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28606572 ● Summary page in Scopus @ Elsevier: 2-s2.0-85025064443 (DOI: 10.1016/j.nut.2017.03.004, PubMed: 28606572, Elsevier: Scopus)
16.	Motoki Kai, Makoto Miyoshi, Mayu Fujiwara, Yuya Nishiyama, Taketo Inoue, Noriaki Maeshige, Yasuhiro Hamada and Makoto Usami : A lard-rich high-fat diet increases hepatic peroxisome proliferator-activated receptors in endotoxemic rats., The Journal of Surgical Research, Vol.212, 22-32, 2017. (Summary) Diets high in saturated fatty acids activate chronic inflammation. We previously reported that, in even acute inflammation caused by lipopolysaccharide (LPS), liver injury was exacerbated in rats fed a lard-rich diet. Peroxisome proliferator-activated receptors (PPARs) are related to inflammation and are also key regulators of lipid metabolism. In this study, we examined effects of high-fat diet on liver injury and hepatic lipid metabolism during endotoxemia, measuring hepatic PPARs and other markers. Male Wistar rats were fed a high-fat diet (HFD, 60 kcal% fat) or control diet (CD, 10 kcal% fat) for 4 or 12 wk, injected with LPS and sacrificed at 0, 1.5, or 6 h. Analyses included plasma aspartate transaminase (AST) and alanine transaminase (ALT) levels, messenger RNA (mRNA) and protein levels of hepatic PPARα and PPARγ, and mRNA levels of enzymes related to fatty acid oxidation and synthesis. Endotoxemic rats on HFD for 12 wk, but not 4 wk, had higher mRNA and protein levels for hepatic PPARs, than did those on CD (P < 0.01-0.05). Similarly, these rats had increased mRNA expression of hepatic fatty acid oxidation- and synthesis-related enzymes (P < 0.01-0.05). Rats injected with LPS had more severe liver injury, indicated by plasma AST/ALT, if on the HFD for 12 wk, compared with for 4 wk. Consumption of a lard-rich diet for 12 wk worsened liver injury and increased hepatic PPARα and PPARγ expression in endotoxemic rats. (Keyword) Animals / Biomarkers / Blotting, Western / Diet, High-Fat / Dietary Fats / Endotoxemia / Lipid Metabolism / Lipopolysaccharides / Liver / Male / oxidative stress / PPAR alpha / PPAR gamma / Random Allocation / Rats / Rats, Wistar / Real-Time Polymerase Chain Reaction (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jss.2016.11.048 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28550910 ● Summary page in Scopus @ Elsevier: 2-s2.0-85010910609 (DOI: 10.1016/j.jss.2016.11.048, PubMed: 28550910, Elsevier: Scopus)
17.	Atsuko Sakai, Hisayo Hamada, Keiko Hara, Kyoko Mori, Takayuki Uchida, Takashi Mizuguchi, Jun Minaguchi, Kenji Shima, Shu Kawashima, Yasuhiro Hamada and Takeshi Nikawa : Nutritional counseling regulates interdialytic weight gain and blood pressure in outpatients receiving maintenance hemodialysis., The Journal of Medical Investigation : JMI, Vol.64, No.1,2, 129-135, 2017. (Summary) Maintenance hemodialysis outpatients must limit salt and water intake to maintain electrolyte balance and blood pressure. In Kawashima Hospital, nationally registered dietitians provide hemodialysis patients with monthly nutritional counseling. We investigated whether nutritional counseling affects interdialytic weight gain (IDWG) and blood pressure. We investigated 48 hemodialysis patients whose monthly average IDWG ratio to dry weight exceeded 5.1% and who had not had a long-term hospital admittance of > 1 month. After the 48-month nutritional counseling period, the IDWG ratio had improved in 37 of the patients (77.1%), significantly decreasing from 6.0±0.7 to 5.3±0.9%. Estimated salt and water intake decreased significantly from 13.3±2.7 to 11.8±2.4 g/day and 2528±455 to 2332±410 ml/day, respectively. During the intervention period, normalized protein catabolic rate and body mass index did not change substantially. Pre-hemodialysis systolic and diastolic blood pressures had significantly decreased from 149±19 to 134±18 mmHg, and 82±13 to 75±10 mmHg for 48 months after study initiation, respectively. The dosage of antihypertensive drugs had significantly decreased in the group that experienced improvement in the IDWG ratio. Long-term nutritional counseling by nationally registered dietitians may improve the IDWG ratio and blood pressure of hemodialysis patients by decreasing their salt and water intake. J. Med. Invest. 64: 129-135, February, 2017. (Keyword) Adult / Ambulatory Care / Antihypertensive Agents / blood pressure / counseling / Female / Humans / hypertension / Male / Middle Aged / Nutrition Therapy / Nutritional Status / Renal Dialysis / Weight Gain (Tokushima University Institutional Repository) ● Metadata: 111100 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.64.129 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28373609 ● Summary page in Scopus @ Elsevier: 2-s2.0-85016435609 (Tokushima University Institutional Repository: 111100, DOI: 10.2152/jmi.64.129, PubMed: 28373609, Elsevier: Scopus)
18.	Sonoko Yasui, Yumiko Shirai, Mayu Tanimura, Sayaka Matsuura, Yu Saitou, Kazuaki Miyata, Eiji Ishikawa, Chikao Miki and Yasuhiro Hamada : Prevalence of protein-energy wasting (PEW) and evaluation of diagnostic criteria and etiology in Japanese maintenance hemodialysis patients, Asia Pacific Journal of Clinical Nutrition, Vol.25, No.2, 292-299, 2016. (Tokushima University Institutional Repository) ● Metadata: 113992 (Link to Publication Site) ● Publication site (DOI): 10.6133/apjcn.2016.25.2.10 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27222412 ● Search Scopus @ Elsevier (PMID): 27222412 ● Search Scopus @ Elsevier (DOI): 10.6133/apjcn.2016.25.2.10 (Tokushima University Institutional Repository: 113992, DOI: 10.6133/apjcn.2016.25.2.10, PubMed: 27222412)
19.	井上善文, 杉浦伸一, 小川哲史, 海塚安郎, 栗山とよ子, 土師誠二, Yasuhiro Hamada, 米倉竹夫 and 日本静脈経腸栄養学会臨床栄養サーベイランス委員会 : The results of a national survey about the present status of clinical nutrition in Japan, The Journal of Japanese Society for Parenteral and Enteral Nutrition, Vol.30, No.6, 1315-1323, 2015. (Link to Publication Site) ● Publication site (DOI): 10.11244/jspen.30.1315 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001205758335232 ● Search Scopus @ Elsevier (DOI): 10.11244/jspen.30.1315 (DOI: 10.11244/jspen.30.1315, CiNii: 1390001205758335232)
20.	井上善文, 杉浦伸一, 小川哲史, 栗山とよ子, 土師誠二, Yasuhiro Hamada, 米倉竹夫 and 日本静脈経腸栄養学会臨床栄養サーベイランス委員会 : The results of a national survey about the present status of clinical nutrition in Japan, The Journal of Japanese Society for Parenteral and Enteral Nutrition, Vol.30, No.5, 1188-1195, 2015. (Link to Publication Site) ● Publication site (DOI): 10.11244/jspen.30.1188 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.11244/jspen.30.1188 (DOI: 10.11244/jspen.30.1188)
21.	井上善文, 杉浦伸一, 小川哲史, 海塚安郎, 栗山とよ子, 土師誠二, Yasuhiro Hamada, 米倉竹夫 and 日本静脈経腸栄養学会臨床栄養サーベイランス委員会 : The results of a survey about the present status of clinical nutrition, The Journal of Japanese Society for Parenteral and Enteral Nutrition, Vol.30, No.4, 987-993, 2015. (Link to Publication Site) ● Publication site (DOI): 10.11244/jspen.30.987 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001205759299712 ● Search Scopus @ Elsevier (DOI): 10.11244/jspen.30.987 (DOI: 10.11244/jspen.30.987, CiNii: 1390001205759299712)
22.	Ken-ichi Miyamoto, Sawako Tatsumi and Yasuhiro Hamada : Clinical Nutrition education in Japanese dietitians, 第60回日本透析医学会, 2015.
23.	Yasuhiro Hamada : Objective Data Assessment (ODA) Methods as Nutritional Assessment Tools., The Journal of Medical Investigation : JMI, Vol.62, No.3-4, 119-122, 2015. (Summary) Nutritional screening and assessment should be a standard of care for all patients because nutritional management plays an important role in clinical practice. However, there is no gold standard for the diagnosis of malnutrition or undernutrition, although a large number of nutritional screening and assessment tools have been developed. Nutritional screening and assessment tools are classified into two categories, namely, subjective global assessment (SGA) and objective data assessment (ODA). SGA assesses nutritional status based on the features of medical history and physical examination. On the other hand, ODA consists of objective data provided from various analyses, such as anthropometry, bioimpedance analysis (BIA), dual-energy X-ray absorptiometry (DEXA), computed tomography (CT), magnetic resonance imaging (MRI), laboratory tests, and functional tests. This review highlights knowledge on the performance of ODA methods for the assessment of nutritional status in clinical practice. J. Med. Invest. 62: 119-122, August, 2015. (Tokushima University Institutional Repository) ● Metadata: 111264 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.62.119 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 26399333 ● Search Scopus @ Elsevier (PMID): 26399333 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.62.119 (Tokushima University Institutional Repository: 111264, DOI: 10.2152/jmi.62.119, PubMed: 26399333)
24.	Mayu Fujiwara, Makoto Miyoshi, Shota Sakai, Aya Nishiokada, Michiko Aoyama-Ishikawa, Noriaki Maeshige, Yu Usami, Yasuhiro Hamada, Michiko Takahashi and Makoto Usami : Lard-based high-fat diet increases secretory leukocyte protease inhibitor expression and attenuates the inflammatory response of acute lung injury in endotoxemic rats., Clinical Nutrition, Vol.34, No.5, 997-1009, 2014. (Summary) Acute lung injury (ALI) is less severe in obese than in nonobese patients, but the mechanism is unclear. Secretory leukocyte protease inhibitor (SLPI) is the key anti-inflammatory protein in various lung diseases. We have previously reported changes of the surgical stress in obese rats using lard-based high-fat diet (HFD). The purpose of this study was to elucidate the effect of lard-based HFD on the pathophysiology of lipopolysaccharide (LPS)-induced ALI, and the role of SLPI expression. Male Wistar rats were fed lard-based HFD (60 kcal% fat) or control diet (CD) for either 4 or 12 weeks and were killed after intraperitoneal LPS injection. Analyses included messenger RNA expression of TNF-, macrophage inflammatory protein (MIP)-2, inducible nitric oxide synthase (iNOS), IL-10 and SLPI in the lung tissue and bronchoalveolar lavage fluid, and histology of the lungs. Rats fed HFD for 12 weeks showed suppression of the lung injury and oxidative stress after LPS injection, as indicated by reduction of pulmonary TNF-, MIP-2 and iNOS mRNA expression and 8-hydroxy-2'-deoxyguanosine immunostaining. The increased pulmonary SLPI caused by lard was associated with decreased pro-inflammatory cytokines and oxidative stress, which eventually resulted in the prevention of ALI. Those effects of lard on LPS-induced ALI were greater after 12 weeks than after 4 weeks feeding, as indicated by the reduction of TNF-, MIP-2 and iNOS levels. Feeding lard-based HFD for 12 weeks attenuated LPS-induced ALI with increased pulmonary SLPI expression in rats. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.clnu.2014.11.001 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25466948 ● Search Scopus @ Elsevier (PMID): 25466948 ● Search Scopus @ Elsevier (DOI): 10.1016/j.clnu.2014.11.001 (DOI: 10.1016/j.clnu.2014.11.001, PubMed: 25466948)
25.	Sachie Negoro, Takaaki Shimohata, Syo Hatayama, Yuri Sato, Mari Matsumoto, Hitomi Iba, Mutsumi Aihara, Takashi Uebanso, Yasuhiro Hamada, Yoshikazu Nishikawa, Shinji Yamasaki, Kazuaki Mawatari and Akira Takahashi : Campylobacter jejuni infection suppressed Cl(-) secretion induced by CFTR activation in T-84 cells., Journal of Infection and Chemotherapy, Vol.20, No.11, 682-688, 2014. (Summary) Campylobacter jejuni causes foodborne disease associated with abdominal pain, gastroenteritis, and diarrhea. These symptoms are induced by bacterial adherence and invasion of host epithelial cells. C. jejuni infection can occur with a low infective dose, suggesting that C. jejuni may have evolved strategies to cope with the bacterial clearance system in the gastrointestinal tract. The mucosa layer is the first line of defense against bacteria. Mucus conditions are maintained by water and anion (especially Cl(-)) movement. Cystic fibrosis transmembrane conductance regulator (CFTR) is the main Cl(-) channel transporting Cl(-) to the lumen. Mutations in CFTR result in dehydrated secreted mucus and bacterial accumulation in the lungs, and recent studies suggest that closely related pathogenic bacteria also may survive in the intestine. However, the relationship between C. jejuni infection and CFTR has been little studied. Here, we used an (125)I(-) efflux assay and measurement of short-circuit current to measure Cl(-) secretion in C. jejuni-infected T-84 human intestinal epithelial cells. The basic state of Cl(-) secretion was unchanged by C. jejuni infection, but CFTR activator was observed to induce Cl(-) secretion suppressed in C. jejuni-infected T-84 cells. The suppression of activated Cl(-) secretion was bacterial dose-dependent and duration-dependent. A similar result was observed during infection with other C. jejuni strains. The mechanism of suppression may occur by affecting water movement or mucus condition in the intestinal tract. A failure of mucus barrier function may promote bacterial adhesion or invasion of host intestinal epithelial cells, thereby causing bacterial preservation in the host intestinal tract. (Tokushima University Institutional Repository) ● Metadata: 110108 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jiac.2014.07.007 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25107576 ● Summary page in Scopus @ Elsevier: 2-s2.0-84908232552 (Tokushima University Institutional Repository: 110108, DOI: 10.1016/j.jiac.2014.07.007, PubMed: 25107576, Elsevier: Scopus)
26.	Aya Nishiokada, Makoto Miyoshi, Mayu Fujiwara, Michiko Aoyama-Ishikawa, Noriaki Maeshige, Michiko Takahashi, Yasuhiro Hamada, Yu Usami, Mie Honda, Makoto Arita and Makoto Usami : Changes of hepatic lipid mediators associated with intake of high-fat diet for 12 weeks in endotoxemic rats using LC-ESI-MS/MS., Clinical Nutrition, Vol.34, No.4, 685-693, 2014. (Summary) It has recently been reported that anti-inflammatory lipid mediators are increased in the late phase of acute inflammation, whereas proinflammatory lipid mediators are regulated at the initiation of inflammation. The purpose of this study was to evaluate changes of hepatic lipid mediators due to high-fat diet (HFD) feeding in endotoxemic rats. Male Wistar rats were fed either HFD or control diet for 12 weeks, and were then killed 0, 1.5, and 6 h after lipopolysaccharide (LPS) injection. Analyses included lipidomics assessment of mediators using liquid chromatography-electrospray ionization/multi-stage mass spectrometry; measuring expression of hepatic polyunsaturated fatty acid (PUFA)-oxidizing enzyme, tumor necrosis factor (TNF)-, interleukin (IL)-6, and inducible nitric oxide synthase mRNA levels; blood biochemical tests; and liver histology. HFD feeding worsened liver injury, increased expression of TNF- and IL-6 mRNA, and increased oxidative stress after LPS injection. PUFA-oxidizing enzymes were higher in HFD-fed rats after LPS injection. The proinflammatory prostaglandin (PG)E2 and thromboxane B2 were increased 1.5 h after LPS injection, and had decreased by 6 h in HFD-fed rats. In contrast, potent pro-resolving resolvins derived from eicosapentaenoic acid and docosahexaenoic acid were not detected, but anti-inflammatory epoxyeicosatrienoic acids, lipoxin A4, and 15-deoxy-PGJ2 were increased after LPS injection in HFD-fed rats. HFD feeding for 12 weeks enhanced proinflammatory lipid mediators 1.5 h after LPS injection suggesting relation to liver injury. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.clnu.2014.07.013 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25131602 ● Summary page in Scopus @ Elsevier: 2-s2.0-84930762096 (DOI: 10.1016/j.clnu.2014.07.013, PubMed: 25131602, Elsevier: Scopus)
27.	Mutsumi Nakahashi, Kazuaki Mawatari, Akiko Hirata, Miki Maetani, Takaaki Shimohata, Takashi Uebanso, Yasuhiro Hamada, Masatake Akutagawa, Yohsuke Kinouchi and Akira Takahashi : Simultaneous irradiation with different wavelengths of ultraviolet light has synergistic bactericidal effect on Vibrio parahaemolyticus., Photochemistry and Photobiology, Vol.90, No.6, 1397-1403, 2014. (Summary) Ultraviolet (UV) irradiation is an increasingly used method of water disinfection. UV rays can be classified by wavelength into UVA (320-400 nm), UVB (280-320 nm), and UVC (< 280 nm). We previously developed UVA sterilization equipment with a UVA-light emitting diode (LED). The aim of this study was to establish a new water disinfection procedure using the combined irradiation of the UVA-LED and another UV wavelength. An oxidative DNA product, 8-hydroxy-2'-deoxyguanosine (8-OHdG), increased after irradiation by UVA-LED alone, and the level of cyclobutane pyrimidine dimers (CPDs) was increased by UVC alone in Vibrio parahaemolyticus. Although sequential irradiation of UVA-LED and UVC induced additional bactericidal effects, simultaneous irradiation with UVA-LED and UVC induced bactericidal synergistic effects. 8-OHdG and CPDs production showed no differences between sequential and simultaneous irradiation. Interestingly, the recovery of CPDs was delayed by simultaneous irradiation. The synergistic effect was absent in SOS response-deficient mutants, such as the recA and lexA strains. Because recA- and lexA-mediated SOS responses have crucial roles in a DNA repair pathway, the synergistic bactericidal effect produced by the simultaneous irradiation could depend on suppression of the CPDs repair. The simultaneous irradiation of UVA-LED and UVC is a candidate new procedure for effective water disinfection. This article is protected by copyright. All rights reserved. (Link to Publication Site) ● Publication site (DOI): 10.1111/php.12309 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25041035 ● Summary page in Scopus @ Elsevier: 2-s2.0-84915794877 (DOI: 10.1111/php.12309, PubMed: 25041035, Elsevier: Scopus)
28.	Ritsuko Ohnishi, Hiroko Segawa, Tomoyo Ohmoto, Shohei Sasaki, Ai Hanazaki, Ayaka Mori, Kayo Ikuta, Junya Furutani, Eri Kawakami, Sawako Tatsumi, Yasuhiro Hamada and Ken-ichi Miyamoto : Effect of dietary components on renal inorganic phosphate (Pi) excretion induced by a Pi-depleted diet., The Journal of Medical Investigation : JMI, Vol.61, No.1-2, 162-170, 2014. (Summary) Dietary inorganic phosphate (Pi) is the most important factor in the regulation of renal Pi excretion. Recent studies suggest the presence of an enteric-renal signaling axis for dietary Pi as well as the existence of a mechanism by which the intestine detects changes in luminal Pi concentrations. The mechanisms of intestinal Pi sensing, however, are unknown. In the present study, we focused on Pi depletion signals and investigated the effects of dietary components on intestinal Pi sensing. After feeding rats experimental diets for 3 days, we investigated urinary Pi excretion and plasma biochemical parameters. Renal Pi excretion was suppressed in rats fed a low-Pi diet (0.02% Pi). Elimination of dietary calcium (Ca) completely blocked the suppression of Pi excretion, suggesting that the presence of Ca is essential for the Pi depletion signal. Furthermore, a minimum Ca content of more than 0.02% was necessary for the Pi depletion signal. Magnesium, lanthanum, and strontium, which are agonists of calcium sensing receptor, instead of Ca, reduced Pi excretion. Therefore, dietary Ca appears to be important for the Pi depletion-sensing mechanism in the gastrointestinal tract. In addition, the calcium sensing receptor may be involved in the Pi depletion signal. (Keyword) dietary phosphate / sensing / calcium / phosphate excretion (Tokushima University Institutional Repository) ● Metadata: 109545 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.61.162 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 24705762 ● CiNii @ National Institute of Informatics (CRID): 1390001204244658176 ● Summary page in Scopus @ Elsevier: 2-s2.0-84897932982 (Tokushima University Institutional Repository: 109545, DOI: 10.2152/jmi.61.162, PubMed: 24705762, CiNii: 1390001204244658176, Elsevier: Scopus)
29.	三好真琴, 宇佐美眞, 藤原麻有, 青山倫子, 前重伯壮, 高橋路子 and Yasuhiro Hamada : 【脂質研究の最近の話題】腸内細菌と脂質代謝, Jomyaku Keicho Eiyo, Vol.28, No.4, 915-921, 2013. (Keyword) *脂質代謝
30.	Shota Sakai, Norihito Iizuka, Mayu Fujiwara, Makoto Miyoshi, Michiko Aoyama, Noriaki Maeshige, Yasuhiro Hamada, Yu Usami and Makoto Usami : Mild obesity reduces survival and adiponectin sensitivity in endotoxemic rats., The Journal of Surgical Research, Vol.185, No.1, 353-363, 2013. (Summary) Recent meta-analyses have reported that critically ill patients with morbid obesity (body mass index >40 kg/m(2)) have poor outcomes, but the effects and mechanisms of action of mild obesity are still unclear. The purpose of this study was to evaluate the effect of mild obesity using a lard-based, high-fat diet (HFD) on pathologic conditions and the mechanisms of adiponectin action in endotoxemic rats. Male Wistar rats underwent HFD feeding for 4 wk and were killed at 0, 1.5, and 6 h after lipopolysaccharide (LPS) injection. Plasma levels of adiponectin, nitric oxide, and interleukin 6; messenger RNA expression of adiponectin receptors (AdipoR1 and AdipoR2) in the liver and the skeletal muscle; blood biochemical test results; and histology of the liver were analyzed. HFD-fed rats had a lower survival rate (12.8% versus 85.2%) and lower plasma adiponectin levels after LPS injection (P < 0.01). Messenger RNA expression of adiponectin receptors in the liver, but not the skeletal muscle, also decreased in HFD-fed rats (P < 0.05). Tissue injury and oxidative stress in the liver and plasma inflammatory mediator levels increased, and worsened lipid metabolism abnormalities were noted. The findings indicated that HFD decreased the sensitivity of adiponectin and was associated with an increase in oxidative stress and inflammation, which finally resulted in worsened liver injury and poor survival rate after LPS injection. Short-term, HFD-induced, mild obesity is harmful to the septic host, reduces adiponectin sensitivity, and could be the cause of worsening pathologic conditions. (Keyword) Adiponectin / brown adipose tissue / Animals / Blood Glucose / Body Weight / Diet, High-Fat / Endotoxemia / Interleukin-6 / Lipid Metabolism / Lipopolysaccharides / Male / Muscle, Skeletal / nitric oxide / obesity / RNA, Messenger / Rats / Rats, Wistar / Receptors, Adiponectin / Severity of Illness Index (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jss.2013.06.002 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23838384 ● Search Scopus @ Elsevier (PMID): 23838384 ● Search Scopus @ Elsevier (DOI): 10.1016/j.jss.2013.06.002 (DOI: 10.1016/j.jss.2013.06.002, PubMed: 23838384)
31.	Yasuhiro Hamada, Yurika Shinohara, Miyuki Yano, Mari Yamamoto, Misa Yoshio, Kumiko Satake, Akiyo Toda, Midori Hirai and Makoto Usami : Effect of the menstrual cycle on serum diamine oxidase levels in healthy women., Clinical Biochemistry, Vol.46, No.1-2, 99-102, 2012. (Summary) Serum diamine oxidase (DAO) level is employed as a useful marker of intestinal mucosal integrity. As reported previously, the range of serum DAO levels in women is wider than that in men. We hypothesized that the menstrual cycle may affect DAO levels. Thirty-six women of Japanese descent were recruited. All participants, aged 20-29 years, were healthy. Food surveys utilized in this study were based on questionnaires validated by dietitians. Complete blood counts, biochemical parameters, female hormones, and serum DAO levels during the follicular and luteal phases were measured in each subject. Biochemical parameters, except for DAO levels, were comparable between the two phases. However, serum DAO levels during the luteal phase were significantly higher than those during the follicular phase. Serum DAO levels were influenced by the menstrual cycle. Furthermore, our findings suggest that serum DAO levels should be interpreted cautiously in premenopausal women. (Keyword) Amine Oxidase (Copper-Containing) / Asian Continental Ancestry Group / Blood Cell Count / Eating / Female / Follicular Phase / Humans / Luteal Phase / Menstrual Cycle / Progesterone / Young Adult (Link to Publication Site) ● Publication site (DOI): 10.1016/j.clinbiochem.2012.10.013 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23099198 ● Search Scopus @ Elsevier (PMID): 23099198 ● Search Scopus @ Elsevier (DOI): 10.1016/j.clinbiochem.2012.10.013 (DOI: 10.1016/j.clinbiochem.2012.10.013, PubMed: 23099198)
32.	Makoto Usami, Makoto Miyoshi, Yoshihiro Kanbara, Michiko Aoyama, Hiroe Sakaki, Katsuhito Shuno, Kenrou Hirata, Masanori Takahashi, Kimihiko Ueno, Yasuhiro Hamada, Shouzou Tabata, Takashi Asahara and Koji Nomoto : Analysis of fecal microbiota, organic acids and plasma lipids in hepatic cancer patients with or without liver cirrhosis., Clinical Nutrition, Vol.32, No.3, 444-451, 2012. (Summary) Changes in the microbiota composition are able to affect nutrient absorption and energy metabolism, but there are few human studies. The aims were to analyze fecal constituents quantitatively and compare them with liver dysfunction in hepatic cancer patients and to evaluate the relationships among intestinal microbiota, fecal organic acids and plasma lipid composition. Fecal samples collected from 46 hepatic cancer patients (with liver cirrhosis, chronic hepatitis or liver fibrosis and normal liver) were evaluated for fecal constituents. Blood organic acid, lipid and fatty acid concentrations were analyzed. Fecal microbiota and organic acids showed no significant differences among different liver dysfunction patients. In normal liver patients, fecal Candida was positively correlated with plasma phospholipid while Bifidobacterium was negatively correlated with plasma eicosapentaenoic acid and eicosapentaenoic acid/arachidonic acid ratio (all p < 0.05). In cirrhotic liver patients, positive correlations were noted for Lactobacillus and docosahexaenoic acid and Candida and eicosapentaenoic acid or eicosapentaenoic acid/arachidonic acid ratio (all p < 0.01). It was suggested that intestinal biota affected serum fatty acid metabolism and were modified by liver disorders. Intestinal microbiota and organic acid concentrations in hepatic cancer patients had positive and/or negative correlations with serum lipid levels. (Keyword) Aged / Arachidonic Acid / Bifidobacterium / Candida / Docosahexaenoic Acids / Eicosapentaenoic Acid / Feces / Female / Humans / Intestines / Lactobacillus / Lipid Metabolism / Lipids / Liver Cirrhosis / Liver Neoplasms / Male / Microbiota / Middle Aged / Phospholipids (Link to Publication Site) ● Publication site (DOI): 10.1016/j.clnu.2012.09.010 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23068014 ● Search Scopus @ Elsevier (PMID): 23068014 ● Search Scopus @ Elsevier (DOI): 10.1016/j.clnu.2012.09.010 (DOI: 10.1016/j.clnu.2012.09.010, PubMed: 23068014)
33.	Shunsuke Goto, Hideki Fujii, Keiji Kono, Kentaro Nakai, Yasuhiro Hamada, Hideyuki Yamato, Masami Shinohara, Riko Kitazawa, Sohei Kitazawa, Shinichi Nishi and Masafumi Fukagawa : Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes., American Journal of Nephrology, Vol.34, No.3, 281-290, 2011. (Summary) Diabetic bone disease is a major complication in diabetes mellitus and is characterized by low-turnover bone formation. Recent studies have demonstrated that oxidative stress could be associated with diabetic bone disease and that -adrenergic antagonists could increase bone formation. Our study investigated the effect of carvedilol (-blocker), possessing an antioxidant effect, on diabetic bone disease. We used the non-obese, type 2 diabetes model Spontaneously Diabetic Torii (SDT) rats in this study. Sprague-Dawley rats were used as controls (control, n = 6). SDT rats were divided into four groups: diabetic (DM, n = 8), DM+insulin (DM+I, n = 7), DM+carvedilol (DM+C, n = 8), and DM+N-acetylcysteine (DM+N, n = 10) at 20 weeks. The rats were sacrificed at 30 weeks, after which blood and urine samples, bone mineral density, histomorphometry, and oxidative stress were evaluated. The number of 8-hydroxydeoxyguanosine-positive cells in bone tissue was significantly lower in the DM+C and DM+N groups than in the DM group. Mineral apposition rate and bone formation rate per bone surface in the DM+C and DM+N groups were significantly higher than those in the DM group, and these parameters were better in the DM+C group than in the DM+N group. Our data suggest that carvedilol has stronger effects on diabetic low-turnover bone disease beyond that which can be attributed to its antioxidative stress mechanism. (Keyword) Adrenergic beta-Antagonists / Animals / Bone Diseases / Carbazoles / Diabetes Complications / Diabetes Mellitus, Type 2 / Male / Propanolamines / Rats / Rats, Sprague-Dawley (Link to Publication Site) ● Publication site (DOI): 10.1159/000330853 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21829007 ● Search Scopus @ Elsevier (PMID): 21829007 ● Search Scopus @ Elsevier (DOI): 10.1159/000330853 (DOI: 10.1159/000330853, PubMed: 21829007)
34.	Yasuhiro Hamada, Sohei Kitazawa, Riko Kitazawa, Keiji Kono, Shunsuke Goto, Hirotaka Komaba, Hideki Fujii, Yasuhiko Yamamoto, Hiroshi Yamamoto, Makoto Usami and Masafumi Fukagawa : The effects of the receptor for advanced glycation end products (RAGE) on bone metabolism under physiological and diabetic conditions., Endocrine, Vol.38, No.3, 369-376, 2010. (Summary) It has been reported that AGEs and the receptor for AGEs (RAGEs) have been linked to the pathogenesis of diabetic microangiopathy. However, the relationship between RAGE and alteration in bone metabolism is unclear. Therefore, in order to determine the role of RAGE in bone metabolism, we investigated the effects of RAGE deletion on bone metabolism under physiological and diabetic conditions using RAGE knockout mice (RAGE-KO). Eight-week-old male RAGE-KO and wild-type littermates (WT) were intraperitoneally injected with either streptozotocin or vehicle. Mice were classified into four groups: (1) nondiabetic WT; (2) nondiabetic RAGE-KO; (3) diabetic WT; and (4) diabetic RAGE-KO. After 12 weeks of streptozotocin or vehicle treatment, the physical properties of femora and the static and dynamic parameters of bone histomorphometry of tibiae were assessed. The deletion of RAGE affected neither body weights nor hemoglobin A1c levels. RAGE deletion resulted in increased bone mineral density due to decreased osteoclast function under physiological conditions that is no accumulation of AGEs. In contrast, lacking RAGE did not affect the alteration in bone metabolism under diabetic conditions, suggesting that AGEs-RAGE interaction may not be involved in the pathogenesis of diabetic osteopenia, although RAGE plays a crucial role in bone metabolism. (Keyword) Absorptiometry, Photon / Animals / Bone Density / Bone Diseases, Metabolic / Bone and Bones / Diabetes Mellitus, Experimental / Glycosylation End Products, Advanced / Male / Mice / Mice, Inbred C57BL / Mice, Knockout / Receptors, Immunologic / Streptozocin (Link to Publication Site) ● Publication site (DOI): 10.1007/s12020-010-9390-9 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 20972729 ● Search Scopus @ Elsevier (PMID): 20972729 ● Search Scopus @ Elsevier (DOI): 10.1007/s12020-010-9390-9 (DOI: 10.1007/s12020-010-9390-9, PubMed: 20972729)
35.	Shunsuke Goto, Hideki Fujii, Yasuhiro Hamada, Kunihiko Yoshiya and Masafumi Fukagawa : Association between indoxyl sulfate and skeletal resistance in hemodialysis patients., Therapeutic Apheresis and Dialysis, Vol.14, No.4, 417-423, 2010. (Summary) Skeletal resistance to parathyroid hormone (PTH) in uremia is known, although the mechanism of resistance is not fully elucidated. To clarify the roles of indoxyl sulfate, which is a uremic toxin, in skeletal resistance, we examined the relationship between indoxyl sulfate and biochemical markers of bone turnover in hemodialysis patients. We obtained blood samples from 47 hemodialysis patients and measured serum indoxyl sulfate, intact PTH, oxidative stress marker 8-hydroxy-2'-deoxyguanosine (8-OHdG), and various biochemical markers. The serum concentrations of alkaline phosphatase (ALP) and bone-specific alkaline phosphatase (BAP) were used as bone formation markers, and the concentration of tartrate-resistant acid phosphatase 5b (TRACP-5b) was used as a bone resorption marker. Serum indoxyl sulfate levels were much higher in hemodialysis patients than healthy subjects. Multiple regression analysis shows that indoxyl sulfate correlated negatively with ALP (beta = -1.897, P = 0.042) and BAP (beta = -0.310, P = 0.029), independent of intact PTH; however, indoxyl sulfate did not correlate with TRACP-5b or 8-OHdG. These findings suggest that indoxyl sulfate may relate skeletal resistance to PTH in uremia. (Keyword) Acid Phosphatase / Adult / Aged / Aged, 80 and over / Alkaline Phosphatase / Biological Markers / Deoxyguanosine / Female / Humans / Indican / Isoenzymes / Male / Middle Aged / Oxidative Stress / Parathyroid Hormone / Regression Analysis / Renal Dialysis (Link to Publication Site) ● Publication site (DOI): 10.1111/j.1744-9987.2010.00813.x (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 20649763 ● Search Scopus @ Elsevier (PMID): 20649763 ● Search Scopus @ Elsevier (DOI): 10.1111/j.1744-9987.2010.00813.x (DOI: 10.1111/j.1744-9987.2010.00813.x, PubMed: 20649763)

Academic Paper (Unrefereed Paper):

1.	Hideya Kashihara, Mitsuo Shimada, Kouzou Yoshikawa, Jun Higashijima, Tomohiko Miyatani, Takuya Tokunaga, Masaaki Nishi, Chie Takasu and Yasuhiro Hamada : The Effect of Laparoscopic Sleeve Gastrectomy on Obesity and Obesity-related Disease : the Results of 10 Initial Cases., The Journal of Medical Investigation : JMI, Vol.66, No.3.4, 289-292, 2019. (Summary) Introduction : The number of patients who undergo laparoscopic sleeve gastrectomy (LSG) has been increasing. Department of Surgery, Tokushima University performed the first LSG in 2013. The aim of this study was to report the results of the initial ten cases who underwent a LSG. Patients and methods : Ten obese patients : five males and five females ; age range from thirty-three years to fifty-six years (mean age 42.2 years) ; mean body mass index (BMI) 50.3 ; five with diabetes ; nine with hypertension (HT) ; four with hyperlipidemia (HL) ; eight with sleep apnea syndrome (SAS) who underwent LSG were enrolled in this study. The data was analyzed retrospectively and included short- and long-term outcomes. Results : There were no post-operative complications in this study. The %EWL at three and six months and one year post-operative were 44.2%, 50.2% and 48.6% respectively. In three months post-operative the non-alcoholic fatty liver (NAFLD) and non-alcoholic steatohepatitis (NASH) had improved transaminase (AST/ALT), liver to spleen ratio in plain CT value. Improvements were also evident in the obesity-related diseases : diabetes 80% (4/5) ; HT 67% (6/9) ; HL 75% (3/4) ; and SAS 88% (7/8). Conclusion : LSG is a promising option for the treatment of morbid obesity and obesity-related diseases. J. Med. Invest. 66 : 289-292, August, 2019. (Tokushima University Institutional Repository) ● Metadata: 114081 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.66.289 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31656291 ● Search Scopus @ Elsevier (PMID): 31656291 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.66.289 (Tokushima University Institutional Repository: 114081, DOI: 10.2152/jmi.66.289, PubMed: 31656291)

Review, Commentary:

1.	Yasuhiro Hamada : たんぱく質の必要量と摂り方の実際, WOC(創傷・オストミー・失禁)予防・治療・ケア特集褥瘡・スキン-テア患者における栄養サポート, Vol.9, No.3, 24-29, Mar. 2021.
2.	Yu Saitou, Yasuhiro Hamada, Sonoko Yasui-Yamada, Tetsuya Ikemoto, Yuji Morine, Satoru Imura and Mitsuo Shimada : 周術期の体組成評価:―サルコペニアの観点より―, The Japanese Journal of Surgical Metabolism and Nutrition, Vol.53, No.4, 147-156, Aug. 2019. (Link to Publication Site) ● Publication site (DOI): 10.11638/jssmn.53.4_147 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.11638/jssmn.53.4_147 (DOI: 10.11638/jssmn.53.4_147)
3.	Yasuhiro Hamada and Arisa Inoue : 【検査値の見方を知ってケアに活かす!透析患者の重要検査&検査値50】(第2章)理学的検査フレイル(解説/特集), 透析ケア 2018 冬季増刊, 216-219, Nov. 2018.
4.	Yasuhiro Hamada, Arisa Inoue, 白井由美子 and 三木誓雄 : 【静脈栄養の力を，今あらためて考える】腎不全の栄養管理における静脈栄養の意義と実際, 日本静脈経腸栄養学会雑誌, Vol.33, No.3, 848-852, Jul. 2018.
5.	Yasuhiro Hamada : 慢性腎臓病の食事療法, 臨床栄養学オープンカレッジ徳島大学大学院開放教室栄養学研究の進め方と論文投稿病態栄養学セミナー, Jul. 2017.
6.	Yasuhiro Hamada : 高リン血症, 1336専門家による私の治療 2017-18年度版, 563, Jul. 2017.
7.	Yasuhiro Hamada : 低リン血症, 1336専門家による私の治療 2017-18年度版, 562, Jul. 2017.
8.	Yasuhiro Hamada : NSTでの実際の管理, 認定NSTガイドブック2017, 277-278, Jul. 2017.
9.	Yasuhiro Hamada : NSTでの実際の管理, 認定NSTガイドブック2017, 274-276, Jul. 2017.
10.	Yasuhiro Hamada : 症候別栄養療法電解質異常，酸・塩基平衡異常, 認定NSTガイドブック2017, 226-235, Jul. 2017.
11.	Yasuhiro Hamada, Yoshiko Tani, Sonoko Yasui and Yu Saitou : 客観的栄養評価(Objective Data Assessment: ODA), Endocrinology, Diabetology & Metabolism, Vol.43, No.3, 185-189, Sep. 2016. (Keyword) Bioelectrical impedance analysis / Nutritional assessment / Rapid turnover protein / Subjective global assessment (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1522543655827288704 (CiNii: 1522543655827288704)
12.	Yu Saitou, Yasuhiro Hamada, Sonoko Yasui, Tetsuya Ikemoto, Yuji Morine, Satoru Imura and Mitsuo Shimada : 【外科領域におけるサルコペニア】周術期サルコペニア発生の予防法, The Japanese Journal of Surgical Metabolism and Nutrition, Vol.50, No.1, 21-28, Feb. 2016. (Keyword) 周術期 / サルコペニア / 予防 (Link to Publication Site) ● Publication site (DOI): 10.11638/jssmn.50.1_21 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390282679740177664 ● Search Scopus @ Elsevier (DOI): 10.11638/jssmn.50.1_21 (DOI: 10.11638/jssmn.50.1_21, CiNii: 1390282679740177664)
13.	Yasuhiro Hamada, Sonoko Yasui and Yu Saitou : CKDにおけるサルコペニア・フレイル対策 CKD患者のサルコペニア・フレイルに対する栄養サポート, 臨床透析, Vol.31, No.8, 1059-1065, 2015.
14.	Sonoko Yasui, Yu Saitou and Yasuhiro Hamada : 栄養療法のピットフォール・よりよい栄養ケアのために Part1.栄養アセスメント Rapid turnover protein値とその解釈, 臨床栄養, Vol.126, No.6, 720-725, May 2015.
15.	Yasuhiro Hamada and Ken-ichi Miyamoto : 病態生理と症例から学ぶ輸液ガイド (第4章)症例から学ぶ輸液療法とその管理の実際低リン血症と高リン血症の是正法と輸液管理, Medical Practice, Vol.32, 204-208, Apr. 2015.
16.	Yasuhiro Hamada : The Importance of Nutritional Management and Nutrition Therapy, Shikoku Acta Medica, Vol.71, No.1-2, 17-22, Apr. 2015. (Summary) Nutritional management plays an important role in medical care. The number of nutrition support team (NST) has been rapidly increased in Japan since 2000. Recently, many medical workers, such as doctor, nurse, pharmacist, and dietitian, are interested in nutritional management and nutrition therapy. For instance, sarcopenic obesity and weight loss in cancer patients are attracting attention. Sarcopenic obesity is defined by the combination of obesity and low muscle mass. This condition is closely related to functional decline and mortality. Sarcopenic obesity is not able to be diagnosed by body weight or body mass index, suggesting that body composition should be also considered. Weight loss is common among patients with cancer. About 50% of patients with cancer report unexplained weight loss at the time of diagnosis, and up to 80% of patients with advanced cancer experience weight loss and cachexia. The weight loss is divided into two types, which are Cancer-Associated Weight Loss (CAWL) and Cancer-Induced Weight Loss (CIWL). Nutritional management and nutrition therapy for weight loss in cancer patients are different between these two types. (Keyword) body composition / nutrition support team / cancer-associated weight loss / cancer-induced weight loss / sarcopenic obesity (Tokushima University Institutional Repository) ● Metadata: 109915 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050020697877544448 (Tokushima University Institutional Repository: 109915, CiNii: 1050020697877544448)
17.	Yu Saitou, Sonoko Yasui, Yasuhiro Hamada, Chie Takasu, Tetsuya Ikemoto, Yuji Morine, Satoru Imura and Mitsuo Shimada : 肝胆膵手術例の術前栄養管理, Surgery, Vol.76, No.11, 1201-1209, Nov. 2014.
18.	Yasuhiro Hamada : 徳島大学医学部医科栄養学科における栄養学教育への取り組み∼臨床栄養学教育(ベッドサイド教育)の強化へ向けて∼, 第29回JSPEN学術集会, Feb. 2014.
19.	Yasuhiro Hamada : Nutritional Management for Protein Energy Wasting (PEW), Shikoku Acta Medica, Vol.69, No.5,6, 211-214, Dec. 2013. (Summary) Nutritional management is related to all kinds of diseases and one of the bases of medical treatment. Chronic kidney disease (CKD) is no exception. Prevalence of chronic kidney disease (CKD) in Japan is estimated to be 13.3million. In addition, the number of dialysis patients in Japan is over 300,000. Recently, because malnutrition in CKD have been paid attention, the International Society of Renal Nutrition and Metabolism (ISRNM) have proposed a new term protein energy wasting (PEW) (Kidney Int. 2008 ; 73(4) : 391‐8). PEW refers to the multiple nutritional and catabolic alterations that occur in patients with CKD and associated with morbidity and mortality. It has been reported that PEW, which is characterized by a decline in body protein mass, muscle and fat wasting and visceral protein pool contraction, is common in patients with dialysis. Various factors such as insufficient food intake due to poor appetite, dietary restriction, increased energy expenditure, acidosis, and persistent inflammation can cause PEW. Because PEW is a factor of bad prognosis, management of PEW should be also paid attention in treatment of patients with CKD. (Keyword) nutritional management / chronic kidney disease (CKD) / acute kidney injury (AKI) / protein energy wasting (PEW) (Tokushima University Institutional Repository) ● Metadata: 109728 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050865122807784704 (Tokushima University Institutional Repository: 109728, CiNii: 1050865122807784704)
20.	Yasuhiro Hamada : 【泌尿器疾患の最新治療と腎疾患・がんの栄養管理】腎疾患患者の栄養障害 Protein Energy Wasting(PEW)に対する栄養管理, Shikoku Acta Medica, Vol.69, No.5-6, 211-214, Dec. 2013. (Keyword) *腎不全-急性(合併症,食事療法)
21.	Yasuhiro Hamada : 栄養指標としてのアルブミン?, Medical Practice, Vol.30, No.11, 1985, Nov. 2013.
22.	Yasuhiro Hamada : 【患者のからだのなかでは何が起こっているの? 管理栄養士が知っておくべき水と電解質のキホン】水素イオン指数 pH, Nutrition Care, Vol.6, No.9, 866-867, Sep. 2013. (Keyword) アシドーシス
23.	Yasuhiro Hamada : 【患者のからだのなかでは何が起こっているの? 管理栄養士が知っておくべき水と電解質のキホン】浸透圧, Nutrition Care, Vol.6, No.9, 868-869, Sep. 2013. (Keyword) Arginine Vasopressin (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1524232505865413888 (CiNii: 1524232505865413888)
24.	Yasuhiro Hamada : 【患者のからだのなかでは何が起こっているの? 管理栄養士が知っておくべき水と電解質のキホン】体液の調節機構, Nutrition Care, Vol.6, No.9, 870-871, Sep. 2013. (Keyword) Arginine Vasopressin
25.	脇田久美子, Yasuhiro Hamada, 堀川真由美, 戸田明代, 西慎一 and 宇佐美眞 : 【透析患者の栄養障害とNSTの可能性】規模別NST活動の展開急性期病院栄養・輸液サポートチーム(NEST)の活動, The Japanese Journal of Clinical Dialysis, Vol.29, No.8, 1195-1201, Jul. 2013. (Keyword) 栄養評価
26.	三木誓雄, Yasuhiro Hamada, Fiaccadori Enrico, Teplan Vladimir, Noeel Cano and Teta Daniel : 【ESPEN-LLLに学ぶ(続編)】 Topic 15 腎疾患における栄養サポート, Jomyaku Keicho Eiyo, Vol.28, No.3, 739-764, May 2013. (Keyword) 栄養状態
27.	宇佐美眞, 三好真琴, 石川[青山] 倫子, 前重伯壮, 田淵寛人, 戸田明代 and Yasuhiro Hamada : 【癌患者に対する栄養療法】癌と栄養代謝癌悪液質の病態, Consensus of Cancer Therapy, Vol.12, No.1, 9-13, Feb. 2013. (Keyword) Interleukin 6
28.	Yasuhiro Hamada and Makoto Usami : [Phosphate metabolism and nutritional therapy in predialysis patients]., Clinical Calcium, Vol.22, No.10, 1577-1582, Oct. 2012. (Summary) Phosphate metabolism is disordered in patients with chronic kidney disease (CKD). Although there is insufficient evidence in predialysis patients, hyperphosphatemia is closely connected with poor prognosis and cardiovascular disease. The standard approaches to management of elevated serum phosphate are dietary restriction and drug treatment using oral phosphate binders. Treatment of hyperphosphatemia is important in patients with CKD. On the other hand, it is possible that dietary restriction causes protein energy wasting (PEW). It is necessary to pay attention to both hyperphosphatemia and PEW in CKD patients. (Keyword) Eating / Humans / Hyperphosphatemia / Phosphates / Phosphorus, Dietary / Renal Dialysis / Renal Insufficiency, Chronic (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23023639 ● Search Scopus @ Elsevier (PMID): 23023639 (PubMed: 23023639)
29.	Makoto Usami, Yasuhiro Hamada and Makoto Miyoshi : [ERAS (enhanced recovery after surgery) Protocol and the evidence]., Masui, Vol.59 Suppl, S8-15, Nov. 2010. (Keyword) Enteral Nutrition / Evidence-Based Medicine / Humans / Patient Care Team / Perioperative Care / Practice Guidelines as Topic (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21692247 ● Search Scopus @ Elsevier (PMID): 21692247 (PubMed: 21692247)

Proceeding of International Conference:

1.	Sonoko Yasui, Yumiko Shirai, Mayu Tanimura, Atsumi Matsubara, Miyu Kubo, Yu Saitou, Kazuaki Miyata, Eiji Ishikawa, Chikao Miki and Yasuhiro Hamada : Possible contributing factors to protein-energy wasting (PEW) in Japanese maintenance hemodialysis patients, The European Society for Clinical Nutrition and Metabolism (ESPEN) Congress, Sep. 2015.
2.	Sonoko Yasui, Yumiko Shirai, Mayu Tanimura, Sayaka Matsuura, Yu Saitou, Kazuaki Miyata, Eiji Ishikawa, Chikao Miki and Yasuhiro Hamada : Prevalence of protein energy wasting (PEW) and evaluation of diagnostic criteria in patients on maintenance hemodialysis, Parenteral and Enteral Nutrition Society of Asia, Nagoya, Vol.25, No.2, 292-299, Nagoya, Jul. 2015. (Summary) The International Society of Renal Nutrition and Metabolism (ISRNM) has recently recommended the use of the term "protein-energy wasting" (PEW). PEW is a state of malnutrition with decreased body stores of protein and energy fuel in hemodialysis patients and is known as a risk factor for morbidity and mortality. We examined the prevalence of PEW and the characteristics of PEW patients in a hemodialysis center in Japan. Fifty-nine outpatients undergoing maintenance hemodialysis at Iga City General Hospital were evaluated. We observed their biochemical data, body composition, dietary intake, and the number of steps prospectively. PEW was defined according to ISRNM criteria. Nine patients (15% of total) were diagnosed as having PEW. Among indicators of PEW criteria, the relevance ratios of "reduced muscle mass" and "unintentional low dietary energy intake" were significantly higher in PEW than in non-PEW. The number of steps was lower, and serum levels of glucose and C-reactive protein were higher in PEW. About 15% of Japanese hemodialysis patients are estimated to have PEW. Our results suggested that major contributing factors to PEW were reduced muscle mass, unintentional low dietary energy intake, lower amount of exercise, insulin resistance, and chronic inflammation. (Keyword) Aged / Blood Glucose / C-Reactive Protein / Comorbidity / Female / Humans / Japan / Male / Prevalence / Protein-Energy Malnutrition / Renal Dialysis / Renal Insufficiency, Chronic / Wasting Syndrome (Link to Publication Site) ● Publication site (DOI): 10.6133/apjcn.2016.25.2.10 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27222412 ● Summary page in Scopus @ Elsevier: 2-s2.0-84979094686 (DOI: 10.6133/apjcn.2016.25.2.10, PubMed: 27222412, Elsevier: Scopus)
3.	Yasuhiro Hamada : Indications and limitations of Parenteral Nutritions, 第16回アジア静脈経腸栄養学会学術集会シンポジウム, Jul. 2015.
4.	Mayu Fujiwara, Makoto Miyoshi, Shota Sakai, Aya Nishiokada, Michiko Aoyama-Ishikawa, Noriaki Maeshige, Yu Usami, Yasuhiro Hamada, Michiko Takahashi and Makoto Usami : Lard-based high-fat diet increases secretory leukocyte protease inhibitor expression and attenuates the inflammatory response of acute lung injury in endotoxemic rats., Clinical Nutrition, Vol.34, No.5, 997-1009, Nov. 2014. (Summary) Acute lung injury (ALI) is less severe in obese than in nonobese patients, but the mechanism is unclear. Secretory leukocyte protease inhibitor (SLPI) is the key anti-inflammatory protein in various lung diseases. We have previously reported changes of the surgical stress in obese rats using lard-based high-fat diet (HFD). The purpose of this study was to elucidate the effect of lard-based HFD on the pathophysiology of lipopolysaccharide (LPS)-induced ALI, and the role of SLPI expression. Male Wistar rats were fed lard-based HFD (60 kcal% fat) or control diet (CD) for either 4 or 12 weeks and were killed after intraperitoneal LPS injection. Analyses included messenger RNA expression of TNF-, macrophage inflammatory protein (MIP)-2, inducible nitric oxide synthase (iNOS), IL-10 and SLPI in the lung tissue and bronchoalveolar lavage fluid, and histology of the lungs. Rats fed HFD for 12 weeks showed suppression of the lung injury and oxidative stress after LPS injection, as indicated by reduction of pulmonary TNF-, MIP-2 and iNOS mRNA expression and 8-hydroxy-2'-deoxyguanosine immunostaining. The increased pulmonary SLPI caused by lard was associated with decreased pro-inflammatory cytokines and oxidative stress, which eventually resulted in the prevention of ALI. Those effects of lard on LPS-induced ALI were greater after 12 weeks than after 4 weeks feeding, as indicated by the reduction of TNF-, MIP-2 and iNOS levels. Feeding lard-based HFD for 12 weeks attenuated LPS-induced ALI with increased pulmonary SLPI expression in rats. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.clnu.2014.11.001 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25466948 ● Summary page in Scopus @ Elsevier: 2-s2.0-84939148963 (DOI: 10.1016/j.clnu.2014.11.001, PubMed: 25466948, Elsevier: Scopus)
5.	Sonoko Yasui, Shirai Yumiko, Miyata Kazuaki, Ishikawa Eiji, Miki Chikao and Yasuhiro Hamada : PREVALENCE OF PROTEIN ENERGY WASTING (PEW) AND EVALUATION OF THE DIAGNOSTIC CRITERIA IN JAPANESE MAINTENANCE HEMODIALYSIS PATIENTS, ESPEN2014, Geneva Switzerland, Sep. 2014.
6.	Nishiokada Aya, Miyoshi Makoto, Fujiwara Mayu, Aoyama-Ishikawa Michiko, Nishiyama Yuya, Kai Motoki, Maeshige Noriaki, Takahashi Michiko, Yasuhiro Hamada, Usami Yu, Arita Makoto and Usami Mkoto : CHANGES OF HEPATIC LIPID MEDIATORS ASSOCIATED WITH INTAKE OF HIGH-FAT DIET FOR 12 WEEKS IN ENDOTOXEMIC RATS USING LC-ESI-MS/MS, ESPEN2014, Geneva Switzerland, Sep. 2014.
7.	Sonoko Yasui, Yumiko Shirai, Kazuaki Miyata, Eiji Ishikawa, Chikao Miki and Yasuhiro Hamada : Prevalence of Protein Energy Wasting (PEW) and evaluation of the diagnostic criteria in Japanese maintenance hemodialysis patients, The European Society for Clinical Nutrition and Metabolism (ESPEN) Congress, Geneva, Sep. 2014.
8.	N. Maeshige, K. Torii, H. Tabuchi, A. Saka, K. Araki, M. A. Ishikawa, M. Imai, Y. Koga, A. Ochi, M. Uemura, M. Miyoshi, Yasuhiro Hamada, H. Terashi and M. Usami : ANTIFIBROGENIC AND PROAPOPTOTIC EFFECTS OF BUTYRATE/DHA VIA PGE2 SECRETION ON KELOID FIBROBLASTS IN INFLAMMATORY MODEL, ESPEN 2013, Aug. 2013.
9.	T. Ikuta, Yasuhiro Hamada, T. Yamaguchi, N. Kitamura, M. Hirai and M. Usami : THE CHARACTERISTICS OF HYPONATREMIA IN PATIENTS WITH MALNUTRITION :OBSERVATIONAL STUDY USING MULTI-FREQUENCY BIOELECTRICAL IMPEDANCE ANALYSIS, Ttokushima, Aug. 2013.
10.	Sonoko Yasui, Shirai Yumiko, Miki Chikao and Yasuhiro Hamada : Prevalence of Protein Energy Wasting (PEW) and evaluation of the diagnostic criteria in maintenance hemodialysis patients:a single-center prospective observational study, Hannover-Tokushima Research Communication, Aug. 2013.

Proceeding of Domestic Conference:

1.	Yasuhiro Hamada : 栄養障害を知る, 日本栄養治療学会医師・歯科医師セミナー, Mar. 2024.
2.	Yasuhiro Hamada : 専門病態栄養看護師に期待するもの∼医師の立場から∼, 第27回日本病態栄養学会学術集会, Jan. 2024.
3.	Sonoko Yasui-Yamada, Miyu Kubo, Yuna Izumi, Kazuhiro Nomura, Seiichiro Kamimura, Hideya Kashihara, Yu Saitou, Yoshiaki Kitamura, Mitsuo Shimada, Yasuhiro Hamada and Hiroshi Sakaue : 簡便に得られるデータから作成した四肢骨格筋量を予測する回帰式の妥当性検証, 第27回日本病態栄養学会年次学術集会, Jan. 2024.
4.	Yasuhiro Hamada : 脊髄疾患により地域包括ケアシステムと密接に関わることとなった一症例, 第6回徳島地域包括ケアシステム学会, Aug. 2023.
5.	Seiya Inoue and Yasuhiro Hamada : 食道癌根治術における術前GLIM criteriaを用いた術後成績の予測, 第38回日本臨床栄養代謝学会学術集会, May 2023.
6.	OMAE Nao, Sonoko Yasui-Yamada, Nanako Hamamiya, YAMANAKA Ayaka, MATSUOKA Momoyo, Seiichiro Kamimura, Yoshiaki Kitamura and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の体組成変化と化学療法中断・生存率との関連, 第26回日本病態栄養学会年次学術集会, Jan. 2023.
7.	HAYAMI Yuna, Sonoko Yasui-Yamada, NAKAMURA Nayu, Miyu Kubo, Satoshi Fujiwara, Seiya Inoue, Masakazu Goto and Yasuhiro Hamada : 食道癌周術期の体重減少に関わる因子の検討, 第26回日本病態栄養学会年次学術集会, Jan. 2023.
8.	NAKAMURA Nayu, Sonoko Yasui-Yamada, HAYAMI Yuna, Arisa Hamano, Seiya Inoue and Yasuhiro Hamada : NST 患者における低 Na 血症改善と死亡率, 第26回日本病態栄養学会年次学術集会, Jan. 2023.
9.	NASU Nanami, Sonoko Yasui-Yamada, TAKIMOTO Mami, Daisuke Sekimoto, Hideya Kashihara, Yu Saitou, Mitsuo Shimada and Yasuhiro Hamada : 膵液瘻高リスク患者における膵頭十二指腸切除術後の早期経口摂取と膵液瘻との関連, 第26回日本病態栄養学会年次学術集会, Jan. 2023.
10.	古本太希, 近藤心, 山田めぐみ, Nori Sato, Seiichiro Kamimura, Yoshiaki Kitamura, Sonoko Yasui-Yamada, Yasuhiro Hamada, Shinsuke Katoh and Tetsuya Matsuura : 化学放射線治療中の頭頚部がん患者に対する理学療法の実施率の違いが筋量，筋力，身体機能に及ぼす影響, 四国理学療法士会学会誌, No.44, 102-103, Nov. 2022.
11.	Chie Takasu, 仲須千春, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Yasuhiro Hamada, 沖川昌平 and Mitsuo Shimada : 肝細胞癌におけるmiRNA-132, 142-5pを介したLenvatinib耐性機序の検討, 第77回日本消化器外科学会総会, Jul. 2022.
12.	Seiya Inoue, Takahiro Yoshida, Masakazu Goto, Satoshi Fujiwara, Mariko Aoyama, Naoya Kawakita, Hiroaki Toba, Hiromitsu Takizawa, 橋本脩平 and Yasuhiro Hamada : 食道癌根治術における術前GLIM criteriaを用いた術後成績の予測, 第122回日本外科学会定期学術集会(ハイブリッド開催), Apr. 2022.
13.	yamanaka ayaka, Sonoko Yasui-Yamada, omae nao, wada kyoko, kitao midori, hayashi haruka, kubo miyu, Yumiko Kurokawa, Yoshiko Suzuki, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌患者における化学放射線療法前のPhase Angleと予後との関連, 第24回・第25回日本病態栄養学会年次学術集会, Jan. 2022.
14.	takimoto mami, Sonoko Yasui-Yamada, nasu nanami, kagiya natsumi, aotani nozomi, Yumiko Kurokawa, Yoshiko Suzuki, Hideya Kashihara, Yu Saitou, Mitsuo Shimada and Yasuhiro Hamada : GLIM(Global Leadership Initiative on Malnutrition)基準の筋肉量減少を判定する指標の検討, 第24回・第25回日本病態栄養学会年次学術集会, Jan. 2022.
15.	Sonoko Yasui-Yamada, nasu nanami, kagiya natsumi, takimoto mami, Yumiko Kurokawa, Hideya Kashihara, Yu Saitou, Mitsuo Shimada and Yasuhiro Hamada : 消化器癌患者において低筋量と低筋力のいずれが予後予測に有用か, 第24回・第25回日本病態栄養学会年次学術集会, Jan. 2022.
16.	Masato Tagi, 田尻真梨, Yasuhiro Hamada, Yoshifumi Wakata, Xiao Shan, Kazumi Ozaki, 久保田雅則, 天野宗佑 and Jun Hirose : Clinical validation of an AI-based system for estimating intake hospital liquid food, 第41回医療情報学連合大会, Nov. 2021.
17.	Yuuma Wada, Mitsuo Shimada, Hideya Kashihara, Kouzou Yoshikawa, Toshihiro Nakao, Takuya Tokunaga, Masaaki Nishi, Chie Takasu, Toshiaki Yoshimoto, Shoko Yamashita, IWAKAWA Yosuke and Yasuhiro Hamada : 肥満外科手術における術前NLRの有用性, 第27回外科侵襲とサイトカイン研究会, Oct. 2021.
18.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, 庄野隆志, 南城和正, Hidenori Maki, Mariko Aoyama, Akira Tangoku, 橋本脩平 and Yasuhiro Hamada : 当院の食道癌集学的チーム医療の現状と栄養評価, 第75回日本食道学会学術集会(ハイブリッド開催), Sep. 2021.
19.	Masato Tagi, 田尻真梨, Yasuhiro Hamada, Yoshifumi Wakata, Xiao Shan, Kazumi Ozaki, 久保田雅則, 天野宗佑 and Jun Hirose : Validation of an AI-based model for estimating leftover liquid food in hospitals, 日本医療情報学会春季学術大会, Vol.25, 70-71, Jun. 2021.
20.	Nozomi Aotani, Sonoko Yasui-Yamada, Natsumi Kagiya, Mayu Tanimura, Yoshiko Suzuki, Hideya Kashihara, Yu Saitou, Mitsuo Shimada and Yasuhiro Hamada : 消化器癌患者における術前栄養評価としてのESPEN提唱栄養不良診断法の臨床的有用性, 第35回日本臨床栄養代謝学会学術集会, Feb. 2020.
21.	Midori Kitao, Sonoko Yasui-Yamada, Kyoko Wada, Miyu Kubo, Yoshiko Suzuki, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の有害事象の頻度と食事摂取への影響について, 第35回日本臨床栄養代謝学会学術集会, Feb. 2020.
22.	Sonoko Yasui-Yamada, Taiki Furumoto, Midori Kitao, Kyoko Wada, Miyu Kubo, Yoshiko Suzuki, Nori Sato, Shinsuke Katoh, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の体組成変化 ∼BIA，エコー，メジャーを用いた経時的評価∼, 第35回日本臨床栄養代謝学会学術集会, Feb. 2020.
23.	Hideya Kashihara, Mitsuo Shimada, Kouzou Yoshikawa, Tomohiko Miyatani, Takuya Tokunaga, Masaaki Nishi, Chie Takasu, Toshiaki Yoshimoto, Yukako Takehara and Yasuhiro Hamada : 非アルコール性脂肪肝炎(NASH)に対する新たな外科治療の開発, 第260回徳島医学会学術集会, Feb. 2020.
24.	Ayami Kashiji, 田尻真梨(徳島大学病院栄養部), Himeno Takasuka, Kotono Ohishi, Arisa Inoue, 筑後桃子(徳島大学病院栄養部), 菊池聡子(徳島大学病院栄養部), Sonoko Yasui-Yamada, Yoshiko Suzuki, 井上聖也(徳島大学病院食道・乳腺甲状腺外科), Hideya Kashihara and Yasuhiro Hamada : 栄養サポートチーム(NST)介入患者における低ナトリウム血症が予後に及ぼす影響の検討, 第35回日本臨床栄養代謝学会学術集会, Feb. 2020.
25.	Midori Kitao, Sonoko Yasui-Yamada, Kyoko Wada, 野村聡子, Yoshiko Suzuki and Yasuhiro Hamada : 喉頭癌CRT 完遂後に経口摂取困難で再入院となった患者に対し，NST による連携で経口摂取が改善した一例, 第23回日本病態栄養学会年次学術集会, Jan. 2020.
26.	Ayami Kashiji, 田尻真梨(徳島大学病院栄養部), Kotono Ohishi, Arisa Inoue, 筑後桃子(徳島大学病院栄養部), 菊池聡子(徳島大学病院栄養部), Sonoko Yasui-Yamada, Yoshiko Suzuki, Hideya Kashihara and Yasuhiro Hamada : 低ナトリウム血症の予後予測因子としての可能性∼栄養サポートチーム(NST)介入患者における生存率の検討∼, 第23回日本病態栄養学会年次学術集会, Jan. 2020.
27.	Nozomi Aotani, Sonoko Yasui-Yamada, Natsumi Kagiya, Mami Takimoto, Mayu Tanimura, Yoshiko Suzuki, Hideya Kashihara, Yu Saitou, Mitsuo Shimada and Yasuhiro Hamada : 消化器癌患者の術前評価におけるESPEN 提唱栄養不良診断基準の各診断項目と予後との関連, 第23回日本病態栄養学会年次学術集会, Jan. 2020.
28.	Kyoko Wada, Sonoko Yasui-Yamada, Midori Kitao, Ayaka Yamanaka, Haruka Hayashi, Miyu Kubo, 野村聡子, Yoshiko Suzuki and Yasuhiro Hamada : 頭頸部癌化学放射線療法における悪液質・非悪液質でのNST 介入効果の比較検討, 第23回日本病態栄養学会年次学術集会, Jan. 2020.
29.	Sonoko Yasui-Yamada, Taiki Furumoto, Midori Kitao, Kyoko Wada, Miyu Kubo, Yoshiko Suzuki, Nori Sato, Shinsuke Katoh, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : NST介入例における頭頸部癌化学放射線療法中の体組成変化∼BIA，エコー，メジャーを用いた評価∼, 第9回日本リハビリテーション栄養学会, Nov. 2019.
30.	Kouzou Yoshikawa, Mitsuo Shimada, Hideya Kashihara, Tomohiko Miyatani, Takuya Tokunaga, Masaaki Nishi, Chie Takasu, Toshiaki Yoshimoto, Yasuhiro Hamada and Sumiko Yoshida : スリーブ状胃切除における術前減量入院の効果とNLRによる術後減量効果予測, 第40回日本肥満学会第37回日本肥満症治療学会学術集会, Nov. 2019.
31.	筑後桃子, Yoshiko Suzuki, Kyoko Nishi, Yasushi Takagi and Yasuhiro Hamada : 当院脳卒中センター(SCU)における栄養サポートチーム(NST)の取り組み―2017年度・2018年度の比較―, 第11回日本静脈経腸栄養学会四国支部会学術集会, Oct. 2019.
32.	Hideya Kashihara, Mitsuo Shimada, Kouzou Yoshikawa, Jun Higashijima, Tomohiko Miyatani, Takuya Tokunaga, Masaaki Nishi, Chie Takasu and Yasuhiro Hamada : スリーブ状胃切除における術前NLRと糖尿病改善についての検討, 第74回日本消化器外科学会総会, Jul. 2019.
33.	Sonoko Yasui-Yamada, Yu Ohiwa, Yu Saitou, Nozomi Aotani, Natsumi Kagiya, Mayu Tanimura, 菊井聡子, Yoshiko Suzuki, Akiko Matsumura, Hideya Kashihara, Mitsuo Shimada and Yasuhiro Hamada : 消化器癌患者における術前栄養・予後指標としてのPhase Angle の臨床的実用性の検討, 日本外科代謝栄養学会, Jul. 2019.
34.	Hideya Kashihara, Mitsuo Shimada, Kouzou Yoshikawa, Jun Higashijima, Tomohiko Miyatani, Takuya Tokunaga, Masaaki Nishi, Chie Takasu and Yasuhiro Hamada : スリーブ状胃切除における多職種介入術前減量入院の効果とNLRによる術後減量効果, 日本外科代謝栄養学会第56回学術集会, Jul. 2019.
35.	Hideya Kashihara, Mitsuo Shimada, Kouzou Yoshikawa, Jun Higashijima, Tomohiko Miyatani, Takuya Tokunaga, Masaaki Nishi, Chie Takasu and Yasuhiro Hamada : スリーブ状胃切除における多職種介入術前減量入院の効果とNLRによる術後減量効果予測, 第119回日本外科学会定期学術集会, Apr. 2019.
36.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, 鈴木恵美, Ryo Yamada, Soichiroh Sasa, Mariko Aoyama, Masami Morimoto, Miyuki Kanematsu, Masakazu Goto, Hirokazu Takechi, Akira Tangoku, Ayami Kashiji and Yasuhiro Hamada : 《ワークショップ》当院における多職種介入による食道癌集学的治療のアウトカム, 第119回日本外科学会定期学術集会, Apr. 2019.
37.	筑後桃子, 西麻希, 菊井聡子, Akiko Matsumura, 兼本ひろみ, 岩野朝香, Hideyuki Takano, Nori Sato, Shinsuke Katoh, Kyoko Nishi, Nobuaki Yamamoto, Yasuhisa Kanematsu, Yasushi Takagi and Yasuhiro Hamada : 当院脳卒中センター(SCU)入院患者における栄養管理―栄養サポートチーム(NST)の取り組み―, 日本脳卒中学会2019, Mar. 2019.
38.	Yasuhiro Hamada : 慢性腎臓病とフレイル・サルコペニア, 第275回名西郡・徳島西医師会学術講演会, Mar. 2019.
39.	Nozomi Aotani, Sonoko Yasui-Yamada, Yu Saitou, Hideya Kashihara, Natsumi Kagiya, Mayu Tanimura, Satoko Kikui, Yoshiko Suzuki, Akiko Matsumura and Yasuhiro Hamada : 消化器癌患者におけるEDC栄養不良診断と各種栄養指標との関連, 第38回食事療法学会, Mar. 2019.
40.	Haruka Hayashi, Sonoko Yasui-Yamada, Midori Kitao, Kyoko Wada, Miyu Kubo, Yoshiko Suzuki, Akiko Matsumura, Asaka Tada, Kunihisa Yamaguchi and Yasuhiro Hamada : 《ポスター発表》腎移植後の体重増加に対し看護師と共同して栄養指導を行った一例, 第38回食事療法学会, Mar. 2019.
41.	Midori Kitao, Sonoko Yasui-Yamada, Haruka Hayashi, Kyoko Wada, Miyu Kubo, Yoshiko Suzuki, Akiko Matsumura, Seichiroh Kamimura, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の有害事象の頻度と経口摂取量への影響, 第38回食事療法学会, Mar. 2019.
42.	Hideya Kashihara, Mitsuo Shimada, Kouzou Yoshikawa, Jun Higashijima, Tomohiko Miyatani, Takuya Tokunaga, Masaaki Nishi, Chie Takasu and Yasuhiro Hamada : 腹腔鏡下胃切除術における多職種介入術前減量プログラムの有用性, 第91回日本胃癌学会総会, Feb. 2019.
43.	Haruka Hayashi, Sonoko Yasui-Yamada, Midori Kitao, Kyoko Wada, Miyu Kubo, Yoshiko Suzuki, Akiko Matsumura, Taiki Furumoto, Nori Sato, Shinsuke Katoh, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の体組成変化と栄養量との関係, 第34回日本静脈経腸栄養学会学術集会, Feb. 2019.
44.	Arisa Inoue, 石川英二, 白井由美子, 村田智博, Ayami Kashiji, Sonoko Yasui-Yamada, Yoshiko Suzuki, 三木誓雄 and Yasuhiro Hamada : 《ポスター発表》Protein-Energy Wasting (PEW) と高リン血症が維持血液透析患者の生命予後に及ぼす影響, 第34回日本静脈経腸栄養学会学術集会, Feb. 2019.
45.	菊井聡子, Sonoko Yasui-Yamada, 西麻希, 筑後桃子, Yoshiko Suzuki, Akiko Matsumura, Hideya Kashihara, Yu Saitou and Yasuhiro Hamada : 肥満を有する肝細胞癌患者に対し肝切除術前に行なった減量の影響, 第22回日本病態栄養学会年次学術集会, Jan. 2019.
46.	Yuho Higashimura, Ayami Kashiji, Arisa Inoue, Kotono Ohishi, Himeno Takasuka, Momoko Chikugo, Satoko Kikui, Sonoko Yasui-Yamada, Yoshiko Suzuki, Akiko Matsumura, Hideya Kashihara and Yasuhiro Hamada : 栄養サポートチーム(NST)における主観的包括的栄養評価(SGA)の有用性の検討, 第22回日本病態栄養学会学術集会, Jan. 2019.
47.	Midori Kitao, Sonoko Yasui-Yamada, Haruka Hayashi, Miyu Kubo, Kyoko Wada, 安原香代美, 井川友美, Yoshiko Suzuki, Akiko Matsumura, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の有害事象の頻度と食事摂取量への影響について, 第22回日本病態栄養学会学術集会, Jan. 2019.
48.	Ayami Kashiji, Yuho Higashimura, Arisa Inoue, Himeno Takasuka, Kotono Ohishi, Momoko Chikugo, Satoko Kikui, Sonoko Yasui-Yamada, Yoshiko Suzuki, Akiko Matsumura, Hideya Kashihara and Yasuhiro Hamada : 《口演》電解質異常が栄養サポートチーム(NST)介入患者の生命予後に及ぼす影響, 第22回日本病態栄養学会学術集会, Jan. 2019.
49.	Nozomi Aotani, Sonoko Yasui-Yamada, Yu Saitou, Hideya Kashihara, Yu Ohiwa, Natsumi Kagiya, Mayu Tanimura, Yoshiko Suzuki, Akiko Matsumura and Yasuhiro Hamada : 消化器癌患者におけるESPEN提唱の栄養不良診断基準の臨床的有用性, 第22回日本病態栄養学会学術集会, Jan. 2019.
50.	Arisa Inoue, 石川英二, 白井由美子, 村田智博, Ayami Kashiji, Sonoko Yasui-Yamada, Yoshiko Suzuki, 三木誓夫 and Yasuhiro Hamada : Protein-Energy Wasting (PEW) と高リン血症の5年生存率に及ぼす影響∼維持血液透析患者での検討∼, 第22回日本病態栄養学会学術集会, Jan. 2019.
51.	Haruka Hayashi, Sonoko Yasui-Yamada, Midori Kitao, Kyoko Wada, Miyu Kubo, Yoshiko Suzuki, Akiko Matsumura, Taiki Furumoto, Nori Sato, Shinsuke Katoh, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の体重変化と栄養組成との関係, 第22回日本病態栄養学会学術集会, Jan. 2019.
52.	Yasuhiro Hamada : NST活動における栄養管理の基礎知識と薬剤師への期待, 徳島県病院薬剤師会学術講演会, Dec. 2018.
53.	Yasuhiro Hamada : 慢性腎臓病(CKD)患者の栄養管理でおさえておくべきポイント, 第48回日本腎臓学会西部学術大会, Sep. 2018.
54.	Haruka Hayashi, Sonoko Yasui-Yamada, Midori Kitao, Kyoko Wada, Miyu Kubo, Yoshiko Suzuki, Taiki Furumoto, Seiichiro Kamimura, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の体組成変化と栄養量との関係について, 第10回日本静脈経腸栄養学会四国支部会学術集会, Sep. 2018.
55.	Momoko Chikugo, Akiko Matsumura, Kyoko Nishi, Yasushi Takagi and Yasuhiro Hamada : 当院SCU入院患者における栄養管理―NSTの取り組み―, 第10回日本静脈経腸栄養学会四国支部会学術集会, Sep. 2018.
56.	Momoko Chikugo, Akiko Matsumura, Kyoko Nishi, Yasushi Takagi and Yasuhiro Hamada : 当院SCU入院患者における栄養管理―NST及び地域とのかかわりについて―, 第2回徳島県地域包括ケアシステム学会, Aug. 2018.
57.	Yasuhiro Hamada : がん状態における臨床栄養管理学, 徳島大学大学院解放教室臨床栄養学オープンカレッジ「がん治療における栄養の役割(基礎と臨床), Jul. 2018.
58.	Arisa Inoue, Eiji Ishikawa, yumiko Shirai, Tomohiro Murata, Chikao Miki and Yasuhiro Hamada : 維持血液透析患者における Protein-Energy Wasting (PEW) と高リン血症の生命予後に及ぼす影響, 第6回日本腎栄養代謝研究会学術集会総会, Jul. 2018.
59.	Seiya Inoue, Takahiro Yoshida, Takeshi Nishino, Masakazu Goto, Akira Tangoku and Yasuhiro Hamada : 食道癌周術期管理における新たな取り組み, 第73回日本消化器外科学会総会, Jul. 2018.
60.	Yasuhiro Hamada : 病院から在宅及び地域包括ケアに向けた栄養療法の支援, 第104回日本消化器病学会総会, Apr. 2018.
61.	古本太希, Sonoko Yasui-Yamada, 近藤心, Nori Sato, Aki Shimada, Noriaki Takeda, Yasuhiro Hamada and Shinsuke Katoh : 化学放射線治療中の頭頸部癌患者に対するリハビリテーション栄養介入が二次性サルコぺニア発生に及ぼす影響, 第33回日本静脈経腸栄養学会, Feb. 2018.
62.	Masami Okitsu, Chisako Nayama, Arisa Inoue, Yuho Higashimura, Ayami Kashiji, Yoshiko Suzuki, Sonoko Yasui-Yamada, 山田静恵, 西麻希, Momoko Chikugo, 橋本脩平, 菊井聡子, Akiko Matsumura and Yasuhiro Hamada : 栄養サポートチーム(NST)介入患者におけるGPSの有用性の検討, 第33回日本静脈経腸栄学会, Feb. 2018.
63.	Yu Ohiwa, Sonoko Yasui-Yamada, Yu Saitou, Nozomi Aotani, Mayu Tanimura, Yoshiko Suzuki, Akiko Matsumura and Yasuhiro Hamada : 消化器癌患者における術前栄養指標としての Phase Angle の臨床的実用性の検討, 第33回日本静脈経腸栄学会, Feb. 2018.
64.	Miyu Kubo, Sonoko Yasui-Yamada, Haruka Hayashi, Midori Kitao, Mayu Tanimura, Yoshiko Suzuki, Yu Saitou, Akiko Matsumura, Seichiroh Kamimura, 三好仁美, Aki Shimada, Noriaki Takeda and Yasuhiro Hamada : 24時間尿中クレアチニン排泄量を用いた頭頸部癌患者の骨格筋量評価, 第33回日本静脈経腸栄学会, Feb. 2018.
65.	Arisa Inoue, 石川英二, 白井由美子, 村田智博, Sonoko Yasui-Yamada, Yoshiko Suzuki, 三木誓雄 and Yasuhiro Hamada : 維持血液透析患者では Protein Energy Wasting (PEW) が高リン血症よりも生命予後に影響する, 第33回日本静脈経腸栄学会, Feb. 2018.
66.	Haruka Hayashi, Sonoko Yasui-Yamada, Miyu Kubo, Midori Kitao, Mayu Tanimura, Yoshiko Suzuki, Yu Saitou, Akiko Matsumura and Yasuhiro Hamada : 初回治療の頭頸部癌患者における悪液質の罹患率とその臨床像, 第33回日本静脈経腸栄学会学術集会, Feb. 2018.
67.	橋本脩平, 西麻希, 山田静恵, Yoshiko Suzuki, Sonoko Yasui-Yamada, 菊井聡子, Akiko Matsumura, 山本ゆかり, 坂東左奈子, 近藤心, Seiya Inoue, Takeshi Nishino, Takahiro Yoshida, Akira Tangoku and Yasuhiro Hamada : 当院における食道癌手術に対するNSTの取り組みと今後の展望について, 第21回日本病態栄養学会年次学術集会, Jan. 2018.
68.	Masami Okitsu, Chisako Nayama, Arisa Inoue, Yuho Higashimura, Ayami Kashiji, Yoshiko Suzuki, Sonoko Yasui-Yamada, 山田静恵, 西麻希, 筑後桃子, 橋本脩平, 菊井聡子, Akiko Matsumura and Yasuhiro Hamada : 栄養サポートチーム介入患者でのGlasgow Prognostic Scoreの有用性の検討, 第21回日本病態栄養学会年次学術集会, Jan. 2018.
69.	Yoshiko Suzuki, Sonoko Yasui-Yamada, 西麻希, Akiko Matsumura and Yasuhiro Hamada : 心臓手術における栄養管理とチーム医療の可能性, 第21回日本病態栄養学会年次学術集会, Jan. 2018.
70.	Yu Ohiwa, Sonoko Yasui-Yamada, Yu Saitou, Nozomi Aotani, Mayu Tanimura, Yoshiko Suzuki, Akiko Matsumura and Yasuhiro Hamada : 消化器癌患者における Phase Angle を用いた術前栄養評価の検討, 第21回日本病態栄養学会学術集会, Jan. 2018.
71.	Masami Okitsu, Chisako Nayama, Arisa Inoue, Yuho Higashimura, Ayami Kashiji, Yoshiko Suzuki, 山田苑子, 山田静恵, 西麻希, 筑後桃子, 橋本脩平, 菊井聡子, Akiko Matsumura and Yasuhiro Hamada : 栄養サポートチーム介入患者の Glasgow Prognostic Score の有用性の検討, 第21回日本病態栄養学会学術集会, Jan. 2018.
72.	菊井聡子, Yoshiko Suzuki, 山田静恵, 西麻希, 粟田由佳, Sonoko Yasui-Yamada, 橋本脩平, 筑後桃子, 小笠有加, 田尻真梨, 樋口康平, 後藤千夏, 加藤ちえ, Akiko Matsumura and Yasuhiro Hamada : 栄養ケアプロセスの導入により明らかとなった疾患ごとの栄養診断結果の特徴, 第21回日本病態栄養学会年次学術集会, Jan. 2018.
73.	Arisa Inoue, 石川英二, 白井由美子, 村田智博, Sonoko Yasui-Yamada, Yoshiko Suzuki, 三木誓雄 and Yasuhiro Hamada : Protein Energy Wasting (PEW)の方が高リン血症よりも維持透析患者において生命予後に影響を与える, 第21回日本病態栄養学会年次学術集会, Jan. 2018.
74.	Arisa Inoue, 石川英二, 白井由美子, 村田智博, Sonoko Yasui-Yamada, Yoshiko Suzuki, 三木誓夫 and Yasuhiro Hamada : Protein Energy Wasting (PEW) の方が高リン血症よりも維持透析患者において生命予後に与える, 第21回日本病態栄養学会学術集会, Jan. 2018.
75.	Chisako Nayama, Masami Okitsu, Arisa Inoue, Ayami Kashiji, Yuho Higashimura, Yoshiko Suzuki, Sonoko Yasui-Yamada, 山田静恵, 西麻希, 筑後桃子, 橋本脩平, 菊井聡子, Akiko Matsumura and Yasuhiro Hamada : Nutrition Support Team (NST)介入患者におけるObesity Paradoxの存在, 第21回日本病態栄養学会年次学術集会, Jan. 2018.
76.	Miyu Kubo, Sonoko Yasui-Yamada, Haruka Hayashi, Midori Kitao, Mayu Tanimura, Yoshiko Suzuki, Yu Saitou, Akiko Matsumura, Seiichiro Kamimura, 三好仁美, Aki Shimada, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌患者において24時間尿中クレアチニン排泄量は骨格筋量評価に有用か, 第21回日本病態栄養学会年次学術集会, Jan. 2018.
77.	Miyu Kubo, 山田苑子, Haruka Hayashi, Midori Kitao, Mayu Tanimura, Yoshiko Suzuki, Yu Saitou, Akiko Matsumura, Seiichiro Kamimura, 三好仁美, Aki Shimada, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌患者において24時間尿中クレアチニン排泄量は骨格筋量評価に有用, The Journal of Metabolism and Clinical Nutrition, Vol.21, Jan. 2018.
78.	Chisako Nayama, Masami Okitsu, Arisa Inoue, Ayami Kashiji, Yuho Higashimura, Yoshiko Suzuki, 山田苑子, 山田静恵, 西麻希, Momoko Chikugo, 橋本脩平, 菊井聡子, Akiko Matsumura and Yasuhiro Hamada : Nurition Support Team (NST) 介入患者における Obesity Paradox の存在, 第21回日本病態栄養学会学術集会, Jan. 2018.
79.	Haruka Hayashi, Sonoko Yasui-Yamada, Miyu Kubo, Midori Kitao, Mayu Tanimura, Yoshiko Suzuki, Yu Saitou, Akiko Matsumura and Yasuhiro Hamada : 頭頸部癌患者における悪液質の罹患率及び各種栄養指標との関連, 第21回日本病態栄養学会学術集会, Jan. 2018.
80.	山田静恵, 菊井聡子, Yoshiko Suzuki, Sonoko Yasui, Akiko Matsumura and Yasuhiro Hamada : 精神症状をきたした低栄養状態に陥った先天性ホモシスチン尿症患者の1症例, 第64回日本栄養改善学会学術総会, Sep. 2017.
81.	菊井聡子, 山田静恵, Yoshiko Suzuki, Sonoko Yasui, Akiko Matsumura and Yasuhiro Hamada : 脳卒中患者における当院の嚥下調整食改訂による効果の検証, 第64回日本栄養改善学会学術総会, Sep. 2017.
82.	Yoshiko Suzuki, Sonoko Yasui, 菊井聡子, 山田静恵, Akiko Matsumura and Yasuhiro Hamada : 心臓リハビリチームにおける栄養管理と管理栄養士の役割, 第64回日本栄養改善学会学術総会, Sep. 2017.
83.	Yasuhiro Hamada : 大学病院における栄養サポートチーム(NST)活動を通してわかったNST活動における医師の役割, 第64回日本栄養改善学会学術総会, Vol.64, Sep. 2017.
84.	Yasuhiro Hamada, Yu Saitou, Yoshiko Suzuki, Sonoko Yasui, 山田静恵, 西麻希, Akiko Matsumura, 高橋路子 and 宇佐美眞 : 栄養サポートチーム(NST)活動の活性化に必要なものとは?, 第42回日本外科系連合学会学術集会, Jun. 2017.
85.	Yasuhiro Hamada : 【シンポジウム】癌の集学的治療と栄養サポートチームのちから栄養サポートチーム活動の活性化に必要なものとは?, 第42回日本外科系連合学会学術集会, Vol.42, Jun. 2017.
86.	橋本脩平, 西麻希, 山田静恵, Yoshiko Suzuki, Sonoko Yasui, 菊井聡子, Akiko Matsumura, 山本ゆかり, 坂東左奈子, 近藤心, Seiya Inoue, Takeshi Nishino, Takahiro Yoshida, Akira Tangoku and Yasuhiro Hamada : 当院における食道癌手術に対するNST 活動について ∼よりよい周術期管理を目指して∼, 第42回日本外科系連合学会学術集会, Jun. 2017.
87.	Sonoko Yasui-Yamada, Aki Shimada, Miyu Kubo, 西麻希, Haruka Hayashi, Yoshiko Suzuki, Akiko Matsumura, 安原香代美, 井川知美, Aki Nakamoto, 三橋知里, 古本太希, 三好仁美, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法を支えるNSTのちから∼当院の病棟NST活動から考える∼, 日本外科系連合会雑誌, Vol.42, Jun. 2017.
88.	Yoshiko Suzuki, Sonoko Yasui, Yu Saitou and Yasuhiro Hamada : 患者の栄養管理を支える栄養サポートチーム(NST), 日本外科系連合学会雑誌, Vol.42, Jun. 2017.
89.	Yu Ohiwa, Sonoko Yasui, Mayu Tanimura, Yoshiko Suzuki, Sayaka Matsura, Yu Saitou, 山田静恵, Akiko Matsumura, Mitsuo Shimada and Yasuhiro Hamada : 消化器癌患者における主観的包括的栄養評価(SGA)による術前栄養評価の妥当性の検討, 日本外科系連合学会雑誌, Vol.42, Jun. 2017.
90.	Chisako Nayama, Yoshiko Suzuki, Sonoko Yasui-Yamada, 粟田由佳, Masami Okitsu, 山田静恵, 西麻希, 菊井聡子, 橋本脩平, Momoko Chikugo, Akiko Matsumura and Yasuhiro Hamada : 不活動状態の高齢脳卒中患者において栄養投与量が筋肉量に及ぼす影響, 栄養-Trend of Nutrition, Vol.2, No.2, 115, Jun. 2017.
91.	Miyu Kubo, Sonoko Yasui-Yamada, Mayu Tanimura, Haruka Hayashi, Midori Kitao, Yoshiko Suzuki, Yu Saitou, Akiko Matsumura, Aki Shimada, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌患者における24時間尿中クレアチニン排泄量を用いた骨格筋量の評価, Trend of Nutrition, Vol.2, No.2, 116, Jun. 2017.
92.	Yasuhiro Hamada : 腎疾患, Vol.Vol.40, Jun. 2017.
93.	Yu Ohiwa, Mayu Tanimura, Sonoko Yasui-Yamada, Yu Saitou, Masaaki Nishi, Matsubara Atsumi, Shizuru Usui, Yoshiko Suzuki, Mitsuo Shimada and Yasuhiro Hamada : 消化器癌患者の術前栄養評価における主観的包括的栄養評価(SGA)の妥当性の検討, Trend of Nutrition, Vol.2, No.2, 110, Jun. 2017.
94.	中本亜樹, 岡田直人, 濱野裕章, Sonoko Yasui, 西麻希, Masaki Imanishi, Yoshito Zamami, 中村敏己, Kazuhiko Teraoka, Yasuhiro Hamada and Keisuke Ishizawa : 頭頸部癌に対する化学放射線療法における CDDP 単独療法及び 52FU+CDDP 療法による副作用発現の比較, 第11回日本緩和医療薬学会年会, Jun. 2017.
95.	古本太希, Sonoko Yasui, Nori Sato, Aki Shimada, Noriaki Takeda, Yasuhiro Hamada and Shinsuke Katoh : 頭頸部がん患者に対する化学放射線治療前後での体組成および身体機能の変化, 第52回日本理学療法学術集会, May 2017.
96.	菊井聡子, Akiko Matsumura, Yoshiko Tani, 山田静恵, 西麻希, 粟田由佳, Sonoko Yasui, 橋本脩平, 足立知咲, 長尾紀子, 小笠有加, 大町はる佳 and Yasuhiro Hamada : 当院の嚥下調整食改定による効果の検証, 第36回日本食事療法学会, Mar. 2017.
97.	Sonoko Yasui, Yu Saitou, Yoshiko Tani, 山田静恵, 粟田由佳, 西麻希, 菊井聡子, 橋本脩平, 足立知咲, Akiko Matsumura, Mitsuo Shimada and Yasuhiro Hamada : NST介入により短期間で体脂肪減量に成功した腹壁瘢痕ヘルニア術前の高度肥満の1症例, 第36回日本食事療法学会, Mar. 2017.
98.	Yoshiko Tani, 粟田由佳, Sonoko Yasui, Masami Okitsu, Chisako Nayama, 山田静恵, 西麻希, 菊井聡子, 橋本脩平, 足立知咲, Akiko Matsumura and Yasuhiro Hamada : 高齢脳卒中患者における不活動が及ぼす筋肉量への影響と栄養投与量との関連, 第32回日本静脈経腸栄養学会学術集会, Feb. 2017.
99.	atsumi Matsubara, Sonoko Yasui, Yu Saitou, Mayu Tanimura, Sayaka Matsura, Yu Ohiwa, 西麻希, 山田静恵, Yoshiko Tani, Akiko Matsumura, Mitsuo Shimada and Yasuhiro Hamada : 胃癌・膵癌患者における術前栄養評価と予後との関連, 第32回日本静脈経腸栄養学会学術集会, Feb. 2017.
100.	Miyu Kubo, Sonoko Yasui, 古本太希, Mayu Tanimura, Atsumi Matsubara, Yoshiko Tani, Akiko Matsumura, Aki Shimada, Nori Sato, Shinsuke Katoh, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の体組成及び筋力の変化, 第32回日本静脈経腸栄養学会学術集会, Feb. 2017.
101.	Miyu Kubo, Sonoko Yasui, 古本太希, Mayu Tanimura, Matsubara Atsumi, Yoshiko Tani, Akiko Matsumura, Aki Shimada, Nori Sato, Shinsuke Katoh, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌患者における化学放射線療法中の体組成変化の検討, 第20回日本病態栄養学会年次学術集会, Jan. 2017.
102.	Masami Okitsu, Yoshiko Tani, Chisako Nayama, 粟田由佳, Sonoko Yasui, 山田静恵, 西麻希, 菊井聡子, 橋本脩平, 足立知咲, Akiko Matsumura and Yasuhiro Hamada : 高齢脳卒中患者における栄養投与量と不活動が及ぼす筋肉量への影響, 第20回日本病態栄養学会年次学術集会, Jan. 2017.
103.	Matsubara Atsumi, Sonoko Yasui, Yu Saitou, Mayu Tanimura, Sayaka Matsura, Yu Ohiwa, 西麻希, 山田静恵, Yoshiko Tani, Akiko Matsumura, Mitsuo Shimada and Yasuhiro Hamada : 胃癌・膵癌患者の予後予測に有用な栄養評価法の検討, 第20回日本病態栄養学会年次学術集会, Jan. 2017.
104.	古本太希, Sonoko Yasui, 近藤心, Toshifumi Ohsawa, Nori Sato, Aki Shimada, Noriaki Takeda, Yasuhiro Hamada and Shinsuke Katoh : 頭頸部がん患者におけるサルコペニア簡易的診断方法の検討, 第38回国立大学リハビリテーション学術大会, Oct. 2016.
105.	Miyu Kubo, Sonoko Yasui-Yamada, 古本太希, Mayu Tanimura, Matsubara Atsumi, Yoshiko Tani, Akiko Matsumura, Aki Shimada, Nori Sato, Shinsuke Katoh, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の体組成及び筋力の変化, 日本静脈経腸栄養学会抄録集, Vol.8, 41, Sep. 2016.
106.	近藤心, 久野恵, 橋本脩平, Sonoko Yasui, Yoshiko Tani, Akiko Matsumura, Nori Sato, Yasuhiro Hamada and Shinsuke Katoh : チームアプローチで経口摂取の再獲得と体力維持が可能であった食道がん術後誤嚥性肺炎の一症例, 第8回日本静脈経腸栄養学会四国支部学術集会, Sep. 2016.
107.	Matsubara Atsumi, Sonoko Yasui, Yu Saitou, Mayu Tanimura, Sayaka Matsura, Yu Ohiwa, Yoshiko Tani, Akiko Matsumura, Mitsuo Shimada and Yasuhiro Hamada : 胃癌・膵癌患者における術前栄養評価と予後との関連, 第8回日本静脈経腸栄養学会四国支部会学術集会, Vol.8, 45, Sep. 2016.
108.	古本太希, Sonoko Yasui, Miyu Kubo, Matsubara Atsumi, Yoshiko Tani, Akiko Matsumura, Nori Sato, Aki Shimada, Noriaki Takeda, Yasuhiro Hamada and Shinsuke Katoh : 化学放射線治療前の頭頸部がん患者におけるサルコペニア簡易診断方法の検討, 第8回日本静脈経腸栄養学会四国支部学術集会, Sep. 2016.
109.	Miyu Kubo, Sonoko Yasui, 古本太希, Mayu Tanimura, Matsubara Atsumi, Yoshiko Tani, Akiko Matsumura, Aki Shimada, Nori Sato, Shinsuke Katoh, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法中の体組成及び筋力の変化, 第8回日本静脈経腸栄養学会四国支部学術集会, Sep. 2016.
110.	Yu Saitou, Sonoko Yasui, Masato Yoshikawa, Hiroki Teraoku, Shin-ichiro Yamada, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Yasuhiro Hamada and Mitsuo Shimada : 肝硬変合併肝切除症例における栄養・免疫状態の特徴, 第52回日本肝癌研究会, Jul. 2016.
111.	白井由美子, Sonoko Yasui, 新谷実希, 石川英二, 三木誓雄 and Yasuhiro Hamada : 慢性維持透析患者における栄養管理∼Protein-Energy Wasting (PEW)に対するアプローチ∼, 第4回日本腎不全栄養研究会学術集会・総会, Jun. 2016.
112.	Yasuhiro Hamada : 静脈栄養管理∼基礎知識から妊婦・授乳婦の対応まで∼, 第7回とくしま妊婦授乳婦薬剤研究会, Mar. 2016.
113.	Mayu Tanimura, Sonoko Yasui, Yu Saitou, Matsubara Atsumi, 山田静恵, Yoshiko Tani, Akiko Matsumura, Mitsuo Shimada and Yasuhiro Hamada : 消化器癌患者における術前栄養評価におけるSGAとODAとの検討, 第31回日本静脈経腸栄養学会, Feb. 2016.
114.	Sonoko Yasui, Mayu Tanimura, Matsubara Atsumi, Rie Tsutsumi, Yoshiko Tani, Akiko Matsumura, 島田亜紀, Hiroshi Sakaue, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法において治療開始時のクレアチニン身長係数が有害事象や治療中断にあたえる影響, 第31回日本静脈経腸栄養学会, Feb. 2016.
115.	Yasuhiro Hamada : 栄養療法協議会パネルディスカッション3 栄養補給法経腸栄養, 第19回日本病態栄養学会, Jan. 2016.
116.	橋本脩平, 大町はる佳, 小笠有加, 長尾紀子, 足立知咲, 菊井聡子, Sonoko Yasui, 西麻希, 山田静恵, Yoshiko Tani, Akiko Matsumura and Yasuhiro Hamada : 「当院の院内約束食事箋」∼消化器疾患∼, 第19回日本病態栄養学会, Jan. 2016.
117.	Mayu Tanimura, Sonoko Yasui, Yu Saitou, Matsubara Atsumi, 山田静恵, Yoshiko Tani, Akiko Matsumura, Mitsuo Shimada and Yasuhiro Hamada : 消化器癌患者におけるSGAを用いた術前栄養スクリーニングとODAの検討, 第19回日本病態栄養学会, Jan. 2016.
118.	Miyu Kubo, Sonoko Yasui, Mayu Tanimura, Matsubara Atsumi, Rie Tsutsumi, Yoshiko Tani, Akiko Matsumura, 島田亜紀, Hiroshi Sakaue, Noriaki Takeda and Yasuhiro Hamada : 頭頸部癌化学放射線療法において治療開始時のクレアチニン身長係数が有害事象に与える影響, 第19回日本病態栄養学会, Jan. 2016.
119.	Yasuhiro Hamada : 酸塩基平衡の異常, 第19回日本病態栄養学会NST講習会(上級編), Jan. 2016.
120.	Yasuhiro Hamada : 栄養アセスメント, 日本病態栄養学会平成27年度教育セミナー, Jan. 2016.
121.	菊井聡子, Yoshiko Tani, 山田静恵, 西麻希, Sonoko Yasui, 橋本脩平, 足立知咲, 長尾紀子, 小笠有加, 大町はる佳, Akiko Matsumura, Yumiko Kotani, 内藤悦雄 and Yasuhiro Hamada : 精神症状をきたし低栄養状態に陥った先天性ホモシスチン尿症患者の1症例, 第19回日本病態栄養学会, Jan. 2016.
122.	Yu Saitou, Sonoko Yasui, 吉川雅登, 寺奥大貴, Shin-ichiro Yamada, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Yasuhiro Hamada and Mitsuo Shimada : 肝胆膵外科手術における免疫指標を加味した新たな周術期栄養評価, 第77回日本臨床外科学会総会, Nov. 2015.
123.	Yasuhiro Hamada : 水分・電解質代謝, 2015JSPE秋季臨床栄養セミナー, Nov. 2015.
124.	Yasuhiro Hamada : 維持血液透析患者における栄養管理, 腎と栄養セミナー, Oct. 2015.
125.	Yasuhiro Hamada : 栄養サポートチーム(NST)が薬剤師に期待することと薬剤師が知っておくべき栄養管理の基礎知識, 徳島県病院薬剤師会学術講演会, Aug. 2015.
126.	Yasuhiro Hamada : 栄養スクリーニング, 徳島県栄養士会, Aug. 2015.
127.	Yasuhiro Hamada : 栄養サポートチームのための実技講習, 日本病態栄養学会平成27年度教育セミナー, Jul. 2015.
128.	Yasuhiro Hamada : 末梢静脈栄養，完全静脈栄養，在宅栄養療法, 日本病態栄養学会平成27年度教育セミナー, Jul. 2015.
129.	Yasuhiro Hamada : もしNSTで腎機能が低下している患者をみつけたら, 第11回能登NST合宿, Jul. 2015.
130.	Yu Saitou, Sonoko Yasui, 寺奥大貴, 吉川雅登, Shin-ichiro Yamada, Chie Takasu, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Yasuhiro Hamada and Mitsuo Shimada : 肝胆膵外科手術における周術期栄養評価の有用性に関する研究-体成分分析装置と主観的包括的アセスメントSGA -, 日本外科代謝栄養学会第52回学術集会, Jul. 2015.
131.	Ken-ichi Miyamoto, Sawako Tatsumi and Yasuhiro Hamada : Clinical Nutrition education in Japanese dietitians., 第60回日本透析医学会学術集会・総会., Jun. 2015.
132.	Yu Saitou, Sonoko Yasui, 吉川雅登, 寺奥大貴, Shin-ichiro Yamada, Shuichi Iwahashi, Yusuke Arakawa, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Yasuhiro Hamada and Mitsuo Shimada : 肝胆膵外科手術におけるNST介入による周術期栄養評価, 第40回日本外科系連合学会学術集会, Jun. 2015.
133.	Yu Saitou, Sonoko Yasui, 吉川雅登, 寺奥大貴, Shin-ichiro Yamada, Shuichi Iwahashi, Yusuke Arakawa, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Yasuhiro Hamada and Mitsuo Shimada : 肝胆膵外科手術における周術期栄養評価の有用性に関する研究‐体成分分析装置と主観的包括的アセスメント‐, 第27回日本肝胆膵外科学会, Jun. 2015.
134.	Yasuhiro Hamada : 腎疾患における栄養管理, 第7回日本静脈経腸栄養学会四国支部学術集会, Jun. 2015.
135.	橋本脩平, 谷佳子, 山田静恵, 西麻希, Sonoko Yasui, 菊井聡子, 足立知咲, 秋山真敏, 大町はる佳, Akiko Matsumura, Takahiro Yoshida and Yasuhiro Hamada : 栄養管理に苦慮した消化吸収障害を伴う食道癌の1症例, 第7回日本静脈経腸栄養学会四国支部学術集会, Jun. 2015.
136.	山田静恵, 谷佳子, 西麻希, Sonoko Yasui, 菊井聡子, 橋本脩平, 足立知咲, 秋山真敏, 大町はる佳, Akiko Matsumura and Yasuhiro Hamada : 神経性無食欲症患者に対するリフィーディング症候群予防への取り組み, 第7回日本静脈経腸栄養学会四国支部会学術集会, Jun. 2015.
137.	Mayu Tanimura, Sayaka Matsura, Sonoko Yasui, Yu Saitou, 山田静恵, 谷佳子, Akiko Matsumura, Mitsuo Shimada and Yasuhiro Hamada : 消化器癌患者の術前栄養評価におけるSGAとODAとの相関, 第7回日本静脈経腸栄養学会四国支部会学術集会, Jun. 2015.
138.	Yumi Kuwamura, 澄川真珠子, Hiromi Murata, 瀧川稲子, 大和光, 石田伸子, 菊井聡子, Yasuhiro Hamada, Hirokazu Ito, Yuko Yasuhara, Daisuke Hinode, Hirokazu Uemura, Ken-ichi Aihara, Munehide Matsuhisa, Tetsuya Tanioka and Toshihiko Nagata : 多職種協働での糖尿病患者の口腔保健行動支援:口腔保健行動を査定するための査定シート案についての糖尿病看護の専門家の評価と実施状況, Journal of the The Japan Diabetes Society, Vol.58, No.supplement 1, S290, May 2015. (Keyword) diabetes / oral health behaviors / nursing
139.	Yu Saitou, Sonoko Yasui, 吉川雅登, 寺奥大貴, Shin-ichiro Yamada, Shuichi Iwahashi, Mami Kanamoto, Yusuke Arakawa, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Yasuhiro Hamada and Mitsuo Shimada : 肝胆膵外科手術における周術期栄養評価の有用性に関する研究-体成分分析装置と主観的包括アセスメントSGA-, 第115日本外科学会定期学術集会, Apr. 2015.
140.	高橋正子, 庄野裕美, Rie Mukai, 井出晋太郎, 朝武宗明, Yasuhiro Hamada and Junji Terao : タマネギケルセチンの生体利用性に対する食べ合わせの効果-同時摂取食材がケルセチン血漿濃度に与える影響-, 日本農芸化学会2015年度大会, Mar. 2015.
141.	Yasuhiro Hamada : NST介入・ステロイド補充にて全身状態が著明に改善した相対的副腎不全の一例, 第30回日本静脈経腸栄養学会, Feb. 2015.
142.	足立知咲, 谷佳子, 山田静恵, 西麻希, Sonoko Yasui, 菊井聡子, 橋本脩平, 長尾紀子, 秋山真敏, 大町はる佳, Akiko Matsumura, Hiroshi Sakaue and Yasuhiro Hamada : 神経性食欲不振症患者の体重増加とエネルギー必要量との関係, 第18回日本病態栄養学会, Jan. 2015.
143.	Yoko Narasaki, Yutaka Taketani, Sayaka Matsura, 森西真由美, 米田武志, 山崎通世, 勝本美咲, Yasuhiro Hamada and Eiji Takeda : 食品毎のリン負荷指数の確立, 第18回日本病態栄養学会年次学術集会平成27年1月10-11日国立京都国際会館, Jan. 2015.
144.	Yasuhiro Hamada : 食品毎のリン負荷指数の確立, 第18回日本病態栄養学会, Jan. 2015.
145.	甲斐元規, 藤原麻有, 三好真琴, 西山雄也, 青山倫子, 前重伯壮, 井上岳人, 植村弥希子, 山下勇人, 高橋路子, Yasuhiro Hamada and 宇佐美眞 : 4週間あるいは12週間ラード含有高脂肪食摂食による急性炎症下の肝組織中脂肪酸分画，脂肪酸酸化酵素・合成酵素の変動, 第12回日本機能性食品医用学会総会, Dec. 2014.
146.	Yasuhiro Hamada : 徳島県下各施設におけるNSTの実際, 第23回徳島NST研究会, Oct. 2014.
147.	古本太希, 谷佳子, Sonoko Yasui, Akiko Matsumura, 出口憲市, Toshifumi Ohsawa, Nori Sato, Tetsuya Enishi, Junichiro Satomi, Yasuhiro Hamada, Shinji Nagahiro and Shinsuke Katoh : 超音波による効果判定法が有用であった非重症SAH 術後の廃用性筋萎縮の一例, 第6回日本静脈経腸栄養学会四国支部学術集会, Sep. 2014.
148.	Sayaka Matsura, Yutaka Taketani, 森西真由美, 米田武志, 山崎通世, 勝本美咲, Yasuhiro Hamada and Eiji Takeda : 食品中リンの生体利用率の評価, 第57回日本腎臓学会, Jul. 2014.
149.	西山雄也, 西岡田亜矢, 藤原麻有, 三好真琴, 甲斐元規, 青山倫子, 山下雄人, 前重伯壮, 高橋路子, Yasuhiro Hamada and 宇佐美眞 : ラード含有高脂肪食投与ラットにおけるエンドトキシン血症下の肝組織中脂質メディエーター変動-LC-ESI-MS/MS解析-, 第51回日本外科代謝栄養学会, Jul. 2014.
150.	Sayaka Matsura, Yutaka Taketani, 森西真由美, 米田武志, 山崎通世, 勝本美咲, Yasuhiro Hamada and Eiji Takeda : 食品中リンの生体利用率の評価, 第57回日本腎臓学会学術総会平成26年7月4-6日パシフィコ横浜, Jun. 2014.
151.	Yutaka Taketani, 松浦明香, 森西真由美, 米田武志, 山崎通世, 勝本美咲, Yasuhiro Hamada and Eiji Takeda : 食品毎のリン生体利用率を利用したリン制限食の可能性, 第2回日本腎不全栄養研究会学術集会・総会平成26年6月29日新大阪ブリックビル, Jun. 2014.
152.	Yutaka Taketani, 森西真由美, 松浦明香, 米田武志, 山崎通世, 勝本美咲, Yasuhiro Hamada, Hisami Okumura and Eiji Takeda : 食品毎のリン生体利用率の違いを利用したリン制限食の可能性, 第2回日本腎不全栄養研究会, Jun. 2014.
153.	Ken-ichi Miyamoto and Yasuhiro Hamada : 腎臓病専門栄養師の設立に向けて, 第59回日本透析医学会学術集会・総会., Jun. 2014.
154.	Ken-ichi Miyamoto and Yasuhiro Hamada : 【ワークショップ】腎臓病専門栄養士設立にむけて, 第59回日本透析医学会, Jun. 2014.
155.	Mami Kanamoto, Yasuhiro Hamada, Yutaka Nakaya, Eiji Takeda, Hisami Okumura, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Hiroki Mori and Mitsuo Shimada : NST介入による周術期栄養管理の有用性に関する検討, 第114回日本外科学会定期学術集会, Apr. 2014.
156.	日高利衣, Yasuhiro Hamada, 堀川真由美, 脇田久美子, 高橋路子 and 宇佐美眞 : 低栄養患者における除脂肪体重量改善に影響する要因の検討, 第29回JSPEN学術集会, Feb. 2014.
157.	Yasuhiro Hamada : 慢性腎臓病(CKD)における栄養管理, 第29回日本静脈経腸栄養学会学術集会, Feb. 2014.
158.	Yumiko Shirai, Sonoko Yasui, Yasuhiro Hamada and Chikao Miki : 維持透析患者におけるProtein Energy Wasting(PEW)に影響を及ぼす各診断項目の評価, 第29回日本静脈経腸栄養学会, Feb. 2014.
159.	Yasuhiro Hamada : 慢性腎臓病(CKD)における栄養管理, 第29回日本静脈経腸栄養学会学術集会ランチョンセミナー, Feb. 2014.
160.	日高りえ, Yasuhiro Hamada, 堀川真由美, 脇田久美子, 高橋路子 and 宇佐美眞 : 栄養・輸液サポートチーム介入患者における除脂肪体重量改善に影響する要因の検討, 第17回日本病態栄養学会年次学術集会, Jan. 2014.
161.	Rie Hidaka(Fujii), Yasuhiro Hamada, Sonoko Yasui, Saki Nakajima, Mayumi Horikawa, Kumiko Wakita, Miyuki Yano, Youko Kobayashi, Michiko Takahashi and Makoto Usami : 栄養・輸液サポートチーム介入患者における除脂肪体重量改善に影響する, 第17回日本病態栄養学会, Jan. 2014.
162.	Yoshiko Tani, Taiki Furumoto, Shizue Yamada, Sonoko Yasui, Akiko Uebanso, Shuhei Hashimoto, Chisaki Adachi, Noriko Nagao, Akiko Matsumura, Eiji Takeda, Yutaka Nakaya, Shinsuke Katoh and Yasuhiro Hamada : くも膜下出血患者における栄養管理がリハビリテーション及び合併症に及ぼす影響, 第17回日本病態栄養学会, Jan. 2014.
163.	Sonoko Yasui, Yumiko Shirai, Chikao Miki and Yasuhiro Hamada : 維持透析患者におけるProtein Energy Wasting(PEW)の頻度と各診断項目の評価, 第17回日本病態栄養学会, Jan. 2014.
164.	Yasuhiro Hamada : 慢性腎臓病(CKD)患者の栄養障害(Protein Energy Wasting:PEW)に対する栄養管理, 三重大学医学部, Dec. 2013.
165.	西岡田亜矢, 藤原麻有, 三好真琴, 甲斐元規, 西山雄也, 高橋路子, 青山倫子, 前重伯壮, Yasuhiro Hamada, 有田誠 and 宇佐美眞 : 高脂肪食投与による肺血症下の肝臓中脂質メディエーターの変化, 第4回機能油脂懇話会, Nov. 2013.
166.	西岡田亜矢, 藤原麻有, 三好真琴, 甲斐元規, 西山雄也, 高橋路子, 青山倫子, 前重伯壮, Yasuhiro Hamada, 有田誠 and 宇佐美眞 : 高脂肪食投与による肺血症下の肝臓中脂質メディエーターの変化, 第4回機能油脂懇話会, Nov. 2013.
167.	太田垣加奈子, 山西美沙, 三ヶ尻礼子, 戸田明代, Yasuhiro Hamada, 宇佐美眞, 村上冴, 新家治子, 徳永俊太郎, 坂下明大 and 西村善博 : -, 第18回日本緩和医療学会学術大会(横浜), Jun. 2013.
168.	Yasuhiro Hamada : Nutritional therapy for Chronic Kidney Disease Mineral and Bone Disorder, 第67回日本栄養・食糧学会大会シンポジウム, May 2013.
169.	Yasuhiro Hamada : Nutritional therapy for Chronic Kidney Disease Mineral and Bone Disorder, May 2013.

Et cetera, Workshop:

1.	Yasuhiro Hamada : 骨粗鬆症患者における栄養管理・栄養療法, メディカルスタッフのための骨粗鬆症と栄養を考える会, Sep. 2023.
2.	野村聡子, Sonoko Yasui-Yamada, Yoshiko Suzuki, 山田静恵, 西麻希, 粟田由佳, 橋本脩平, 筑後桃子, Hideya Kashihara, Yu Saitou and Yasuhiro Hamada : 肥満を有する肝細胞癌の患者に対する術前減量プロトコールの評価, 第260回徳島医学会学術集会, Feb. 2020.
3.	Sonoko Yasui-Yamada, Yu Ohiwa, Nozomi Aotani, Natsumi Kagiya, Mami Takimoto, 野村聡子, Yoshiko Suzuki, Hideya Kashihara, Yu Saitou, Masaaki Nishi, Mitsuo Shimada and Yasuhiro Hamada : 消化器癌患者における術前栄養・予後指標としてのPhase angleの臨床的実用性の検討, 第260回徳島医学会学術集会, Feb. 2020.
4.	Yasuhiro Hamada : これだけは知っておこう!栄養管理の基礎知識, 第3回徳島県地域包括ケアシステム学会学術集会, Aug. 2019.
5.	Yuho Higashimura, Yoshiko Suzuki, Kotono Ohishi, 石井亜由美, 西川幸治, Sonoko Yasui-Yamada, Takayuki Ise, Shusuke Yagi, Akiko Matsumura, Masataka Sata and Yasuhiro Hamada : 心臓リハビリテーションと連携し，継続した栄養介入を行うことで減量が認められた一例, 日本心臓リハビリテーション学会第3回四国支部地方会, Apr. 2019.
6.	Yasuhiro Hamada : 栄養管理の基礎知識, 阿波なかつむぎプロジェクトフォーラム, Jan. 2019.
7.	Ayami Kashiji, Yuho Higashimura, Arisa Inoue, Himeno Takasuka, Kotono Ohishi, 筑後桃子, 菊井聡子, Sonoko Yasui-Yamada, Yoshiko Suzuki, Akiko Matsumura, Hideya Kashihara and Yasuhiro Hamada : 栄養サポートチーム(NST)介入患者における電解質異常が生命予後に及ぼす影響について, 第27回徳島NST研究会, Oct. 2018.
8.	Arisa Inoue, 石川英二, 白井由美子, 村田智博, 三木誓雄 and Yasuhiro Hamada : Protein-Energy Wasting (PEW) と高リン血症が維持血液透析患者の5年生存率に及ぼす影響, 第27回徳島NST研究会, Oct. 2018.
9.	Taiki Furumoto, Sonoko Yasui-Yamada, 近藤心, Akiko Matsumura, Nori Sato, Seiichiro Kamimura, Noriaki Takeda, Yasuhiro Hamada and Shinsuke Katoh : 化学放射線治療中の頭頸部癌患者における二次性サルコペニアの発生状況, 第10回日本静脈経腸栄養学会四国支部会学術集会, Sep. 2018.
10.	菊井聡子, Sonoko Yasui-Yamada, 林明希, 武田滋郁, 西麻希, Yoshiko Suzuki, Yu Saitou, Hideya Kashihara, Akiko Matsumura and Yasuhiro Hamada : 多職種の連携によりストマ周囲潰瘍の改善がみられた高齢患者の1症例, 第10回日本静脈経腸栄養学会四国支部会学術集会, Sep. 2018.
11.	Akiko Matsumura, Satoko Kikui, Sonoko Yasui-Yamada, Yoshiko Suzuki, Yu Saitou, Hideya Kashihara, 吉野真理子 and Yasuhiro Hamada : 病院間で栄養管理を繋いだ一症例, 第10回日本静脈経腸栄養学会四国支部会学術集会, Sep. 2018.
12.	Momoko Chikugo, Akiko Matsumura, Kyoko Nishi, Yasushi Takagi and Yasuhiro Hamada : 当院SCU入院患者における栄養管理 ―NST及びチーム医療の取り組み―, 第20回脳卒中研究会, Feb. 2018.
13.	Yasuhiro Hamada : 腎疾患における栄養管理と栄養評価, 栄養-Trend of Nutrition, Vol.2, No.2, 126, Jun. 2017.
14.	Chisako Nayama, Yoshiko Tani, 粟田由佳, Sonoko Yasui, Masami Okitsu, 山田静恵, 西麻希, 菊井聡子, 橋本脩平, Chisaki Adachi, Akiko Matsumura, Shinji Nagahiro and Yasuhiro Hamada : 高齢脳卒中患者における短期不活動下での筋肉量変化と栄養投与量の関連, 第254回徳島医学会学術集会, Feb. 2017.
15.	Yoshiko Tani, Sonoko Yasui, Masami Okitsu, Chisako Nayama, Akiko Matsumura and Yasuhiro Hamada : 心臓リハビリチームにおける管理栄養士の役割と課題, -, Jan. 2017.
16.	古本太希, Nori Sato, 出口憲市, Sonoko Yasui, Yoshiko Tani, Akiko Matsumura, Yasuhiro Hamada, Junichiro Satomi, Shinji Nagahiro and Shinsuke Katoh : 非重症くも膜下出血の術後早期における大腿外側部筋厚値の変化, 第18回徳島脳卒中研究会, Feb. 2016.
17.	Yasuhiro Hamada : 慢性腎臓病に関する基礎知識と栄養管理, 第21回愛媛NST研究会, Jun. 2015.
18.	Yu Saitou, Sonoko Yasui, 吉川雅登, 寺奥大貴, 山田眞一郎, Shuichi Iwahashi, Mami Kanamoto, Yusuke Arakawa, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Yasuhiro Hamada and Mitsuo Shimada : InBodyを用いた体組成分析の肝胆膵外科手術における周術期栄養評価の有用性に関する検討, 第249回徳島医学会学術集会, Jul. 2014.
19.	Mami Kanamoto, Yasuhiro Hamada, Yutaka Nakaya, Eiji Takeda, Hisami Okumura, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Hiroki Mori and Mitsuo Shimada : NST介入による周術期栄養管理の有用性に関する検討, Journal of Japan Surgical Society, Vol.115, No.2, 782, Mar. 2014. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1573105977706375936 (CiNii: 1573105977706375936)
20.	Yasuhiro Hamada : 徳島大学医学部医科栄養学科における栄養学教育への取り組み∼臨床栄養学教育(ベッドサイド教育)の強化へ向けて∼, 第29回日本静脈経腸栄養学会学術集会パネルディスカッション, Feb. 2014.
21.	Sonoko Yasui, Yoshiko Tani, Taiki Furumoto, Shizue Yamada, Akiko Uebanso, Shuhei Hasimoto, Chisaki Adachi, Akiko Matsumura, Eiji Takeda, Yutaka Nakaya, Shinsuke Katoh and Yasuhiro Hamada : くも膜下出血患者における栄養管理がリハビリテーションに及ぼす影響, 第16回徳島脳卒中研究会, Feb. 2014.
22.	Yasuhiro Hamada : 【ミニレクチャー】CKD-MBDからの栄養管理, 第29回ROD-21研究会, Jan. 2014.
23.	Yasuhiro Hamada, Sonoko Yasui and Ken-ichi Miyamoto : 医学部における栄養学教育の問題点と展望徳島大学医学部医科栄養学科における栄養学教育への取り組み臨床栄養学教育(ベッドサイド教育)の強化へ向けて, Jomyaku Keicho Eiyo, Vol.29, No.1, 275, Jan. 2014. (Keyword) *医学大学教育
24.	日高[藤井] 利衣, Yasuhiro Hamada, 堀川真由美, 脇田久美子, 高橋路子 and 宇佐美眞 : 低栄養患者における除脂肪体重量改善に影響する要因の検討, Jomyaku Keicho Eiyo, Vol.29, No.1, 303, Jan. 2014. (Keyword) *体重と身体計測
25.	白井由美子, Sonoko Yasui, Yasuhiro Hamada and 三木誓雄 : 維持透析患者におけるProtein Energy Wasting(PEW)に影響を及ぼす各診断項目の評価, Jomyaku Keicho Eiyo, Vol.29, No.1, 347, Jan. 2014. (Keyword) *血液透析
26.	Yasuhiro Hamada : 医療における栄養管理の重要性∼NST活動を中心とした取り組み∼, 講演赤穂市, Dec. 2013.
27.	Yasuhiro Hamada : 泌尿器疾患の最新治療と腎疾患・がんの栄養管理腎疾患患者の栄養障害 Protein Energy Wasting(PEW)に対する栄養管理, Shikoku Acta Medica, Vol.69, No.5-6, 295, Dec. 2013. (Keyword) *腎臓疾患(合併症,食事療法)
28.	Yasuhiro Hamada : 栄養スクリーニング, 2013秋季コメディカル教育セミナー京都, Sep. 2013.
29.	Yasuhiro Hamada : 水分・電解質代謝, 2013年秋季コメディカル教育セミナー京都, Sep. 2013.
30.	Yoshiko Tani, Yuka Tomoe, Michiyo Satou, Yuki Ono, Tomoyo Morimoto, Michika Harada, Shizu Nakayama, Shizue Yamada, Sonoko Yasui, Akiko Matsumura, Shinji Nagahiro, Yutaka Nakaya and Yasuhiro Hamada : 脳卒中急性期にはタンパク質を多く投与しても窒素出納は負になる, 日本静脈経腸栄養学会四国支部会学術総会, Sep. 2013.
31.	Sonoko Yasui, Yumiko Shirai, Chikao Miki and Yasuhiro Hamada : 維持血液透析患者におけるProtein Energy Wasting (PEW)および各診断項目の評価∼単施設における観察研究∼, 日本静脈経腸栄養学会四国支部会学術総会, Sep. 2013.
32.	高橋美貴, 松澤洋子, 脇田久美子, 谷本均, 齋藤幹, 南川勉, 古森孝英, 戸田明代, Yasuhiro Hamada and 宇佐美眞 : 口腔癌・上顎癌治療後の摂食・嚥下カンファレンス介入の実際, Japanese Journal of Speech, Language, and Hearing Research, Vol.10, No.3, 189, Sep. 2013. (Keyword) 栄養評価
33.	Sonoko Yasui, Yumiko Shirai, Chikao Miki and Yasuhiro Hamada : Prevalence of Protein Energy Wasting (PEW) and evaluation of the diagnostic criteria in maintenance hemodialysis patients: a single-center prospective observational study, International Symposium Hannover-Tokushima Research Communication, Aug. 2013.
34.	生田智子, Yasuhiro Hamada, 山口徹郎, 北村直子, 平井みどり and 宇佐美眞 : 低栄養患者に生じる低ナトリウム血症の要因の検討, The Japanese Journal of Surgical Metabolism and Nutrition, Vol.47, No.4, 126, Aug. 2013. (Keyword) Sodium(血液)
35.	高橋美貴, 松澤洋子, 脇田久美子, 谷本均, 齋藤幹, 南川勉, 古森孝英, 戸田明代, Yasuhiro Hamada and 宇佐美眞 : 口腔癌・上顎癌治療後の摂食・嚥下カンファレンス介入の実際, The Japanese Journal of Surgical Metabolism and Nutrition, Vol.47, No.4, 127-128, Aug. 2013. (Keyword) 栄養評価
36.	藤井利衣, Yasuhiro Hamada, 堀川真由美, 矢野美由紀, 小林曜子, 北秋翔子, 脇田久美子, 戸田明代 and 宇佐美眞 : 低栄養患者の栄養評価における体成分分析装置の有用性について, The Japanese Journal of Surgical Metabolism and Nutrition, Vol.47, No.4, 128, Aug. 2013. (Keyword) Serum Albumin
37.	Yasuhiro Hamada : 【ディスカッション】骨代謝・腎不全に対する最新の知見, 第6回慢性腎臓病病態研究会, Jul. 2013.
38.	Yasuhiro Hamada : 大学病院におけるNST活動の実際, 第26回四国地区TNT研修会(徳島大学医学部公舎内・保健学科), Jun. 2013.
39.	太田垣加奈子, 山西美沙, 三ヶ尻礼子, 戸田明代, Yasuhiro Hamada, 宇佐美眞, 村上冴, 新家治子, 徳永俊太郎, 坂下明大 and 西村善博 : 緩和ケアチームにおける管理栄養士の活動内容と役割について, 日本緩和医療学会学術大会プログラム・抄録集, 400, Jun. 2013. (Keyword) *緩和ケア
40.	Yasuhiro Hamada : ミネラル摂取と老化制御 Klotho研究から見えるミネラル管理の重要性慢性腎臓病におけるミネラル摂取管理の重要性, 日本栄養・食糧学会大会講演要旨集, 43, Apr. 2013. (Keyword) 骨疾患-代謝性(病因)
41.	前重伯壮, 荒木杏子, 坂安優未, 鳥井一宏, 田淵寛人, 石川[青山] 倫子, 三好真琴, 植村弥希子, 今井緑, Yasuhiro Hamada, 寺師浩人 and 宇佐美眞 : TGF-β1/IL-1β刺激下ケロイド線維芽細胞のapoptosis耐性および線維形成亢進に対する酪酸・DHAの制御作用, 日本栄養・食糧学会大会講演要旨集, 185, Apr. 2013. (Keyword) *Docosahexaenoic Acids
42.	Yasuhiro Hamada and 大久保惠子 : 腎不全患者の栄養障害 Protein Energy Wastingへの対応を考える腎不全患者の栄養障害討論用症例提示, Jomyaku Keicho Eiyo, Vol.28, No.1, 270, Jan. 2013. (Keyword) *栄養障害(病因,治療)
43.	白井由美子, Yasuhiro Hamada, 町野友美, 阿波賢一, 樋口徳宏 and 三木誓雄 : 腎不全患者の栄養障害 Protein Energy Wastingへの対応を考える当院における透析患者の栄養管理の実際栄養士の立場から, Jomyaku Keicho Eiyo, Vol.28, No.1, 271, Jan. 2013. (Keyword) *血液透析
44.	藤井利衣, Yasuhiro Hamada, 堀川真由美, 矢野美由紀, 小林曜子, 北秋翔子, 脇田久美子, 戸田明代 and 宇佐美眞 : 低栄養患者における多周波インピーダンス法を用いた体成分分析測定について, Jomyaku Keicho Eiyo, Vol.28, No.1, 396, Jan. 2013. (Keyword) 体内水分
45.	坂田安紀子, Yasuhiro Hamada, 堀川真由美, 藤井利衣, 小林曜子, 矢野美由紀, 菊間知恵, 野口依子, 北秋翔子, 脇田久美子, 戸田明代 and 宇佐美眞 : 栄養・輸液サポートチーム(NEST)活動への多周波インピーダンス法による体成分分析装置の導入について, Jomyaku Keicho Eiyo, Vol.28, No.1, 499, Jan. 2013. (Keyword) *栄養評価
46.	小林曜子, Yasuhiro Hamada, 矢野美由紀, 山本麻里, 菊間知恵, 野口依子, 北秋翔子, 甲津彩子, 小林沙織, 脇田久美子, 山西美沙, 戸田明代, 平井みどり and 宇佐美眞 : 健常女性における血中diamine oxidase(DAO)活性に及ぼす因子の検討, Jomyaku Keicho Eiyo, Vol.28, No.1, 513, Jan. 2013. (Keyword) *Amine Oxidase (Copper-Containing)(血液)
47.	生田智子, Yasuhiro Hamada, 山口徹郎, 北村直子, 平井みどり and 宇佐美眞 : 低栄養患者における低ナトリウム血症生体インピーダンス法を用いた検討, Jomyaku Keicho Eiyo, Vol.28, No.1, 553, Jan. 2013. (Keyword) 体内水分
48.	高橋美貴, 竹本菜保子, 佐野彩香, 木内亮平, 松澤洋子, 脇田久美子, Yasuhiro Hamada, 谷本均, 齋藤幹, 大月直樹, 丹生健一 and 宇佐美眞 : 中咽頭癌に対する同時併用化学放射線療法における経皮内視鏡的胃瘻造設術を用いた栄養管理, Jomyaku Keicho Eiyo, Vol.28, No.1, 560, Jan. 2013. (Keyword) *胃造瘻術

Report:

1.	Kazumi Ozaki, Yasuhiko Shirayama, Tetsuo Ichikawa, Miwa Matsuyama, Yasuhiro Hamada, Shinsuke Katoh, 濱田邦美, Teruyoshi Kageji, 藤原真治, Shizuko Yanagisawa, Akari Watanabe, Mariko Seyama and Yuko Takeuchi : 中山間地域の通いの場におけるオーラルフレイル予防対策を起点とした地域住民の包括的支援に関する調査研究事業∼``見える化''・``つなぐ化''プロジェクト∼, 令和2年度厚生労働省老人保健事業推進費等補助金(老人保健健康増進等事業) 報告書, 1-98, Mar. 2021. (Keyword) ICT / オーラルフレイル / 高齢者サロン
2.	Kazumi Ozaki, Yasuhiko Shirayama, Tetsuo Ichikawa, Miwa Matsuyama, Yasuhiro Hamada, Shinsuke Katoh, 濵田邦美, Teruyoshi Kageji, 藤原真治, Shizuko Yanagisawa, Natsumi Fujiwara and Yuko Takeuchi : 令和元年度老人保健事業推進費等補助金(老人保健健康増進等事業)中山間地域における地域住民との連携によるオーラルフレイル予防のためのICT利活用の強化・進展に関する調査研究事業「とくしま助INTプロジェクト」報告書, 1-94, Mar. 2020.
3.	Kazumi Ozaki, Yasuhiko Shirayama, Shinsuke Katoh, Tetsuo Ichikawa, Yasuhiro Hamada, Shizuko Yanagisawa, Natsumi Fujiwara and Yuko Takeuchi : 平成30年度老人保健事業推進費等補助金(老人保健健康増進等事業)中山間地域におけるICT利活用によるフレイル・オーラルフレイル予防のためのベストプラクティス確立・普及に関する調査研究事業「阿波なかつむぎプロジェクト」報告書, 1-92, Mar. 2019.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

Establishment of efficient and effective nutrition evaluation method in nutrition support team (NST) (Project/Area Number: 18K11100 )
Development of integrated treatment for impaired liver regeneration on non-alcoholic steatohepatitis (Project/Area Number: 18H02871 )
Usefulness of Subjective Global Asessment in Gastrointestinal Cancer (Project/Area Number: 16K12722 )
Development of multidisciplinary therapy for aged liver insufficiency based on the mechanism of hepatic stellate cell dysfunction. (Project/Area Number: 26293288 )
Involvement of oxidative stress and check points in CKD-MBD (Project/Area Number: 25461247 )
The Role of Receptor for AGEs(RAGE) on Low Turnover Bone (Project/Area Number: 22790790 )
Role and Action of New Stimulants and inhibitors on Bone Metabolism in Chronic Kidney Disease (Project/Area Number: 19590950 )
Search by Researcher Number (30397830)

Professor : Hamada, Yasuhiro

Research

Personal Web Page

Field of Study

Subject of Study

Book / Paper

Book:

Academic Paper (Judged Full Paper):

Academic Paper (Unrefereed Paper):

Review, Commentary:

Proceeding of International Conference:

Proceeding of Domestic Conference:

Et cetera, Workshop:

Report:

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)